Disorders of refraction and accommodation

H7_REFRAACCOMMODIS

obsolete_refractive error: ['Deviations from the average or standard indices of refraction of the eye through its dioptric or refractive apparatus.']

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H52 Cause of death: ICD-10 — H52 2 out of 7 registries used, show all original rules.	13071
4. Check minimum number of events None	13071
5. Include endpoints H7_HYPERMETRO H7_MYOPIA H7_ASTIGMATISM H7_ANISOMETROPIA H7_PRESBYOPIA H7_ACCOMMODIS H7_REFRADISNAS	13522
6. Filter based on genotype QC (FinnGen only)	12909

Control definitions (FinnGen only)

Control exclude: H7_OCUMUSCLE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H49-H52
Name in latin: Perturbationes refractionis et accommodationis (oculi)

NAME	H7_REFRAACCOMMODIS
CONTROL_EXCLUDE	H7_OCUMUSCLE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	H7_HYPERMETRO\|H7_MYOPIA\|H7_ASTIGMATISM\|H7_ANISOMETROPIA\|H7_PRESBYOPIA\|H7_ACCOMMODIS\|H7_REFRADISNAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H52
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H52
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Disorders of refraction and accommodation based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	129024	71773	56859
Only index persons	107279	60800	46479
Unadjusted period prevalence (%)
Whole population	1.84	2.06	1.59
Only index persons	2.04	2.24	1.77
Median age at first event (years)
Whole population	16.51	19.23	12.93
Only index persons	25.00	29.26	19.42

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	12909	8527	4382
Unadjusted period prevalence (%)	2.68	3.02	2.01
Median age at first event (years)	48.07	46.19	51.73

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
13517: Matched controls
134630

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H52.0

ICD-10 Finland

Hypermetropia

86.9

307.7

2867

416

H50.30

ICD-10 Finland

Intermittent esotropy

194.1

307.7

211

H50.52

ICD-10 Finland

Exophoria

33.9

307.7

319

H50.31

ICD-10 Finland

Intermittent exotropia

154.7

307.7

259

H52.3

ICD-10 Finland

Anisometropia and aniseikonia

92.6

307.7

1079

126

H52.1

ICD-10 Finland

Myopia

87.7

307.7

5836

1156

Z96.1

ICD-10 Finland

Presence of intraocular lens

3.5

307.7

1825

5807

H52.2

ICD-10 Finland

Astigmatism

77.3

307.7

2526

399

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.5

307.7

6147

33939

CGD20

NOMESCO Finland

Laser-assisted in situ keratomileusis

498.6

307.7

621

CGD10

NOMESCO Finland

Laser keratoplasty for error of refraction

113.2

307.7

493

H53.0

ICD-10 Finland

Amblyopia ex anopsia

19.9

307.7

498

258

H50.1

ICD-10 Finland

Divergent concomitant strabismus

203.2

307.7

201

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

2.2

307.7

4303

23591

XCK00

NOMESCO Finland

Perimetry

3.9

307.7

1044

2862

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.5

307.7

2837

12892

H52.5

ICD-10 Finland

Disorders of accommodation

108.1

307.7

287

H52.4

ICD-10 Finland

Presbyopia

23.6

307.7

2609

1351

XCW99

NOMESCO Finland

Other investigative procedure of eye

3.6

307.7

1867

5801

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

2.8

307.7

3486

14908

H50.0

ICD-10 Finland

Convergent concomitant strabismus

384.5

302.5

304

H50.2

ICD-10 Finland

Vertical strabismus

43.8

226.6

135

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.7

225.8

1309

5095

H26.4

ICD-10 Finland

After-cataract

2.9

220.3

1103

3970

H53.2

ICD-10 Finland

Diplopia

4.8

213.9

499

1073

H50.51

ICD-10 Finland

Esophoria

31.8

209.6

136

CJB10

NOMESCO Finland

Laser discission of secondary cataract

3.0

195.8

927

3229

CEC10

NOMESCO Finland

Recession and resection of extraocular muscle

470.0

187.4

187

H25.0

ICD-10 Finland

Senile incipient cataract

3.1

175.0

778

2611

H53.1

ICD-10 Finland

Subjective visual disturbances

2.6

171.9

1071

4301

H04.10

ICD-10 Finland

Dry eye syndrome

2.2

167.6

1635

7997

ZXA10

NOMESCO Finland

Bilateral

1.9

164.2

2307

12887

37002

ICD-8 Finland

Refractive errors, Myopia

+∞

160.5

154

H44.2

ICD-10 Finland

Degenerative myopia

27.4

160.0

109

H25.1

ICD-10 Finland

Senile nuclear cataract

1.9

158.9

2206

12260

CG2T4

NOMESCO Finland

Topography assessment of cornea

7.6

158.2

224

296

H40.0

ICD-10 Finland

Glaucoma suspect

2.5

154.2

1012

4161

H26.02

ICD-10 Finland

Presenil cataract

3.8

136.0

430

1161

37300

ICD-8 Finland

Strabismus, Concomitans convergens

+∞

134.4

129

37001

ICD-8 Finland

Refractive errors, Hypermetropia. Hyperopia

+∞

129.2

124

H33.0

ICD-10 Finland

Retinal detachment with retinal break

3.8

128.2

398

1061

CJE40

NOMESCO Finland

Phakoemulsification with implantation of skleralt fixed artificial lens in posterior chamber

61.9

122.0

37301

ICD-8 Finland

Strabismus, Concomitans divergens

+∞

121.9

117

CG2X4

NOMESCO Finland

Optical coherence tomography (OCT) of cornea

8.2

109.8

146

179

WX100

NOMESCO Finland

Conjunctival surface anesthesia

2.1

105.1

1084

5372

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

3.7

103.6

340

941

XCK10

NOMESCO Finland

Photography of fundus of eye

2.1

101.1

1036

5119

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.3

99.3

756

3311

H18.6

ICD-10 Finland

Keratoconus

6.5

93.8

153

236

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.0

92.7

1099

5722

CGD99

NOMESCO Finland

Other operation for error of refraction

49.1

92.6

3671A

ICD-9 Finland

Disorders of refraction and accommodation, Myopia

+∞

91.6

37000

ICD-8 Finland

Refractive errors, Astigmatismus

+∞

89.5

WX140

NOMESCO Finland

Parabulbar anesthesy

2.7

86.8

480

1806

R51.80

ICD-10 Finland

Headache

1.6

84.2

2201

14427

S01ED51

ATC

timolol, combinations; ophthalmic

2.2

81.7

689

3147

H52

ICD-10 Finland

Disorders of refraction and accommodation

10.1

81.6

CEC00

NOMESCO Finland

Recession of extraocular muscle

800.3

81.4

H33.3

ICD-10 Finland

Retinal breaks without detachment

2.7

79.7

427

1580

H51.1

ICD-10 Finland

Convergence insufficiency and excess

166.3

79.0

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.9

78.7

1133

6282

Z94.7

ICD-10 Finland

Corneal transplant status

8.9

76.5

107

114

Kela drug reimbursment

Glaucoma

2.1

74.9

714

3423

H35.4

ICD-10 Finland

Peripheral retinal degeneration

5.3

74.8

152

290

Z3229

NOMESCO Finland

Other healthcare associate professional

1.9

74.2

957

5116

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.9

73.4

959

5148

H50.9

ICD-10 Finland

Strabismus, unspecified

15.2

73.0

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

71.6

1023

5653

CJE99

NOMESCO Finland

Other extracapsular cataract operation using phakoemulsification technique

23.2

70.3

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

2.7

70.0

388

1461

H55

ICD-10 Finland

Nystagmus and other irregular eye movements

7.8

68.4

120

XCD10

NOMESCO Finland

Electrophysiological examination of eye

3.1

65.4

285

942

H54.7

ICD-10 Finland

Unspecified visual loss

5.2

65.1

133

255

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

3.0

64.1

292

990

CKC12

NOMESCO Finland

Photocoagulation of retina

2.3

63.4

475

2062

R42

ICD-10 Finland

Dizziness and giddiness

1.5

63.1

2322

16328

37303

ICD-8 Finland

Strabismus, Heterophoria (exophoria, esophroria, hypophoria)

+∞

61.4

AA1AD

NOMESCO Finland

CT of head and brain

1.5

61.4

2509

18007

XA800

NOMESCO Finland

Neuropsychological investigation

2.1

60.9

573

2730

F79.0

ICD-10 Finland

Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour

7.5

60.2

115

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

157.6

59.8

CHC05

NOMESCO Finland

Iridotomy

3.8

59.8

186

497

H26.2

ICD-10 Finland

Complicated cataract

3.9

59.5

176

454

CGG45

NOMESCO Finland

Full thickness transplantation of cornea using homograft

12.0

58.7

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

2.4

58.0

400

1673

XCH00

NOMESCO Finland

Eye pressure measurement

2.2

57.2

477

2166

3503

FHL

Single muscle retroposition

558.3

56.6

37720

ICD-8 Finland

Other diseases of retina and optic nerve, Amblyopia

22.8

56.1

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

55.6

4598

37149

P85

ICPC

Mental retardation

7.1

55.0

115

S01EE01

ATC

latanoprost; ophthalmic

2.1

54.5

503

2378

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

51.9

2527

18669

ZXA00

NOMESCO Finland

Right side

1.4

51.7

2515

18579

H49.1

ICD-10 Finland

Fourth [trochlear] nerve palsy

176.6

50.8

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

50.0

1257

8091

H25.8

ICD-10 Finland

Other senile cataract

1.8

49.4

766

4329

H53.4

ICD-10 Finland

Visual field defects

3.0

49.3

227

775

Z3231

NOMESCO Finland

Registered nurse

1.4

48.6

3038

23390

H17.8

ICD-10 Finland

Other corneal scars and opacities

7.7

48.1

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

47.2

781

4498

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

3.4

46.9

171

508

H40.11

ICD-10 Finland

Low pressure glaucoma

3.1

46.3

192

617

TAB00

NOMESCO Finland

Lumbar puncture

2.0

45.4

541

2808

ZXA05

NOMESCO Finland

Left side

1.4

45.2

2293

17017

ZXE00

NOMESCO Finland

One hour or less

1.3

45.1

4401

36137

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

2.4

44.9

313

1316

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.2

44.8

405

1899

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.2

44.7

367

1656

S01EE05

ATC

tafluprost; ophthalmic

2.4

44.7

310

1301

N03AX12

ATC

[U] gabapentin; oral

1.5

44.5

1658

11613

CS494

NOMESCO Finland

Other visual field testing

2.6

44.1

256

988

CJF10

NOMESCO Finland

Secondary implantation of artificial lens in posterior chamber

15.0

44.0

H43.3

ICD-10 Finland

Other vitreous opacities

3.1

44.0

184

595

S01BA07

ATC

fluorometholone; ophthalmic

3.0

43.6

197

666

N06AX11

ATC

mirtazapine; oral

1.3

42.7

3742

30210

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

42.3

2817

21828

S01EC04

ATC

brinzolamide; ophthalmic

2.3

42.0

316

1375

Z2445

NOMESCO Finland

Psychologist

1.8

41.5

602

3332

E0000UV, ,

ATC

1.3

41.4

5026

42347

S01EA05

ATC

brimonidine; ophthalmic

2.8

40.9

209

756

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

40.4

3703

30038

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

2.5

40.3

251

1002

N03AG01

ATC

valproic acid; systemic, rectal

1.8

40.0

664

3825

F83

ICD-10 Finland

Mixed specific developmental disorders

3.4

39.9

143

421

N06AX21

ATC

duloxetine; oral

1.5

39.7

1310

8937

H53.3

ICD-10 Finland

Other disorders of binocular vision

5.3

39.5

149

G44.2

ICD-10 Finland

Tension-type headache

1.4

39.2

1623

11580

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

39.2

2806

21952

N03AX09

ATC

lamotrigine; oral

1.8

39.0

642

3689

Q87.88

ICD-10 Finland

Other specified congenital malformation syndromes, not elsewhere classified

10.8

38.9

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

4.9

38.3

168

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.5

38.3

1342

9266

CS1H4

NOMESCO Finland

Retinal nerve fibre layer imaging

2.7

38.2

211

795

S01ED01

ATC

timolol; ophthalmic

2.4

37.9

273

1165

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.8

37.8

561

3125

CHD05

NOMESCO Finland

Selective lasertrabeculoplasty

2.3

37.4

283

1234

TCG10

NOMESCO Finland

Removal of sutures from cornea

5.5

37.2

132

Z2221

NOMESCO Finland

Medical doctor

1.3

37.2

3034

24163

H47.2

ICD-10 Finland

Optic atrophy

5.4

37.0

136

N05BA01

ATC

diazepam; systemic, rectal

1.5

37.0

1271

8741

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

36.8

1460

10328

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

36.7

2490

19297

CHD00

NOMESCO Finland

Laser trabeculoplasty

3.7

36.7

117

319

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

2.9

36.6

169

579

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

4.2

36.4

228

S01EC01

ATC

acetazolamide; systemic

2.6

36.3

209

804

WX002

NOMESCO Finland

Sedation and analgesia

1.4

36.2

1836

13576

WX142

NOMESCO Finland

Sub-tenon anesthesy

4.6

36.0

181

TCC40

NOMESCO Finland

Closure of lacrimal canaliculus with plug

6.3

36.0

ZXD20

NOMESCO Finland

Day surgery

1.5

35.8

1342

9388

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.8

35.4

569

3247

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.1

35.3

353

1721

H02AB09

ATC

hydrocortisone; systemic

2.2

34.7

309

1442

G47.3

ICD-10 Finland

Sleep apnoea

1.4

34.5

2220

17044

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

2.6

34.5

200

772

Z31.5

ICD-10 Finland

Genetic counselling

1.7

34.4

693

4211

N03AX16

ATC

[U] pregabalin

1.4

34.3

2261

17422

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

34.1

630

3739

A02BC05

ATC

esomeprazole; systemic

1.3

33.9

4224

35459

R62.0

ICD-10 Finland

Delayed milestone

3.3

33.8

129

395

H18.5

ICD-10 Finland

Hereditary corneal dystrophies

3.5

33.7

115

328

N02AX02

ATC

tramadol; systemic, rectal

1.3

33.4

4322

36435

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

33.3

2951

23709

UDC00

NOMESCO Finland

Ear microscopy

1.6

33.2

797

5059

N03AX11

ATC

topiramate; oral

2.1

33.2

328

1593

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

3.7

33.1

103

276

H57.1

ICD-10 Finland

Ocular pain

1.9

33.0

446

2413

Z2446

NOMESCO Finland

Social worker

1.6

33.0

793

5034

3507

FHL

Retroposition and resection

169.7

32.7

CEC30

NOMESCO Finland

Resection of extraocular muscle

+∞

32.2

3670A

ICD-9 Finland

Disorders of refraction and accommodation, Hypermetropia

+∞

32.2

CEC60

NOMESCO Finland

Transposition of extraocular muscle with adjustable suture

+∞

32.2

TCG30

NOMESCO Finland

Imaging of anterior and posterior part of cornea

9.5

32.2

183

Kela drug reimbursment

Lamotrigin and topiramate

3.0

32.0

142

476

N03AX14

ATC

levetiracetam; systemic

2.1

31.9

305

1463

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

31.9

1397

10052

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.6

31.8

773

4921

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

2.7

31.6

171

638

N05CF01

ATC

zopiclone; oral

1.3

31.5

3009

24387

H02AB06

ATC

prednisolone; systemic

1.2

31.5

5044

43499

N05AH04

ATC

quetiapine; oral

1.3

31.5

2054

15784

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

3.7

31.4

268

R03AC02

ATC

salbutamol; inhalant

1.2

30.9

6603

58702

N06AX16

ATC

venlafaxine; oral

1.4

30.8

1664

12407

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

30.5

1506

11060

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.2

30.5

245

1097

F29

ICPC

Eye symptom/complaint other

1.5

30.4

1056

7265

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

30.3

2608

20834

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

30.1

1015

6943

R20.2

ICD-10 Finland

Paraesthesia of skin

1.6

30.1

786

5088

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

1.9

29.9

409

2222

Q87.4

ICD-10 Finland

Marfan syndrome

9.2

29.9

XKC03

NOMESCO Finland

Water cystometry

2.1

29.8

277

1315

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

154.7

29.6

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

29.6

4327

36865

TPH04

NOMESCO Finland

Cathetrisation of vein

1.3

29.5

2125

16553

F05

ICPC

Visual disturbance other

2.0

29.3

319

1606

K07.60

ICD-10 Finland

Snapping jaw

1.6

29.2

649

4041

S01BA04

ATC

prednisolone; ophthalmic

2.4

29.1

200

837

3780A

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Convergent concomitant strabismus[STRABISMUS CONCOMITANS CONVERGENS]

+∞

29.1

G35

ICD-10 Finland

Multiple sclerosis

2.4

28.9

203

858

H35.5

ICD-10 Finland

Hereditary retinal dystrophy

5.0

28.9

121

N05CF02

ATC

zolpidem; oral

1.4

28.8

1795

13679

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.5

28.7

929

6298

602

Kela drug reimbursment

Children's severe malnutrition

3.7

28.7

252

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.5

28.7

832

5511

R53

ICD-10 Finland

Malaise and fatigue

1.3

28.7

2582

20732

RL140, ,

NOMESCO Finland

6.0

28.7

H50.8

ICD-10 Finland

Other specified strabismus

33.6

28.6

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

28.5

2397

19072

N06AB04

ATC

citalopram; systemic

1.3

28.5

2098

16388

XKD00

NOMESCO Finland

Uroflowmetry

1.5

28.4

1073

7505

C07AA05

ATC

propranolol; systemic

1.3

28.1

2313

18341

J02AC01

ATC

fluconazole; systemic

1.2

28.1

4575

39385

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.4

28.0

1620

12199

Z3226

NOMESCO Finland

Physiotherapist

1.3

28.0

1833

14071

A02BC03

ATC

lansoprazole; oral

1.3

27.9

2632

21255

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

27.8

3924

33240

F82

ICD-10 Finland

Specific developmental disorder of motor function

3.4

27.8

286

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

27.8

1394

10258

H02.4

ICD-10 Finland

Ptosis of eyelid

2.1

27.6

254

1201

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

27.6

983

6793

H33.5

ICD-10 Finland

Other retinal detachments

3.5

27.2

266

3780B

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Convergent concomitant strabismus[STRABISMUS CONVERGENS ALTERNANS]

+∞

27.0

3782B

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Intermittent heterotropia[STRABISMUS DIVERGENS INTERMITTENS]

+∞

27.0

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

26.9

848

5716

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

26.8

1527

11467

M79.6

ICD-10 Finland

Pain in limb

1.2

26.8

4606

39825

N03AF02

ATC

oxcarbazepine; oral

1.9

26.7

353

1899

CKD92

NOMESCO Finland

Combined vitrectomy and retinal procedure

2.9

26.5

121

413

H01AC01

ATC

somatropin; parenteral

3.6

26.3

244

SPAT1263

SPAT

Sampling

1.2

26.2

4801

41753

R4120

NOMESCO Finland

Occupational therapy

1.6

26.2

656

4204

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.6

26.0

545

3343

CEW99

NOMESCO Finland

Other operation on extraocular muscle

+∞

26.0

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.4

25.9

1298

9542

CKC60

NOMESCO Finland

Local buckling of sclera using implant

4.4

25.9

149

R4110

NOMESCO Finland

Physiotherapy

1.3

25.8

2741

22429

SPAT1260

SPAT

Consultation of another employee

1.3

25.8

1806

13984

H54.5

ICD-10 Finland

Severe visual impairment, monocular

4.3

25.5

151

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.3

25.4

1734

13375

UKC02

NOMESCO Finland

Cystoscopy

1.4

25.3

1178

8554

H18.7

ICD-10 Finland

Other corneal deformities

10.3

25.2

UJF32

NOMESCO Finland

Coloscopy

1.3

24.7

2306

18561

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

24.7

2127

16944

CKC10

NOMESCO Finland

Local photocoagulation of retina

2.6

24.6

147

577

G04BD12

ATC

mirabegron; oral

1.5

24.6

885

6125

A02BC02

ATC

pantoprazole; systemic

1.2

24.6

7284

66225

N02BE01

ATC

paracetamol; systemic, rectal

1.3

24.6

10750

101660

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

24.5

2737

22512

H16.0

ICD-10 Finland

Corneal ulcer

1.7

24.5

511

3131

L17

ICPC

Foot/toe symptom/complaint

1.3

24.5

3028

25202

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

24.5

2823

23307

N05BA09

ATC

clobazam; oral

3.1

24.5

104

341

A98

ICPC

Health maint/preventive medicine

1.6

24.5

13043

127047

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.8

24.4

346

1902

N03AE01

ATC

clonazepam; systemic

1.6

24.4

531

3291

CKD91

NOMESCO Finland

Extended vitrectomy through pars plana

2.8

24.0

119

425

R06.0

ICD-10 Finland

Dyspnoea

1.3

24.0

2470

20116

3680A

ICD-9 Finland

Visual disturbances, Amblyopia ex anopsia

55.9

24.0

WX402

NOMESCO Finland

General anaesthesia

1.3

23.9

2292

18497

WX110

NOMESCO Finland

Infiltration anesthesia

1.2

23.7

8986

83489

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.8

23.7

392

2257

N05BA04

ATC

oxazepam; oral

1.3

23.6

2657

21862

H03AA01

ATC

levothyroxine sodium; systemic

1.3

23.4

2299

18612

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

23.3

4953

43564

R55

ICD-10 Finland

Syncope and collapse

1.4

22.9

923

6527

3672A

ICD-9 Finland

Disorders of refraction and accommodation, Astigmatism

+∞

22.9

3781B

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Divergent concomitant strabismus[STRABISMUS DIVERGENS ALTERNANS]

+∞

22.9

XCD00

NOMESCO Finland

Clinical examination of eye in general anaesthesia

7.6

22.8

R01AD09

ATC

mometasone; nasal

1.2

22.7

5365

47618

F79.9

ICD-10 Finland

Unspecified mental retardation, without mention of impairment of behaviour

8.5

22.6

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

2.7

22.4

120

447

CKC30

NOMESCO Finland

Cryopexy of detached retina

4.2

22.3

141

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

22.2

1936

15425

L04AX01

ATC

azathioprine; systemic

1.7

22.1

452

2757

R35

ICD-10 Finland

Polyuria

1.6

22.1

533

3386

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

22.1

4960

43789

SPAT1301

SPAT

No procedures

1.2

22.0

3266

27676

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.5

22.0

774

5335

WX199

NOMESCO Finland

Other local analgesia

1.9

21.9

276

1462

R5140

NOMESCO Finland

Monitoring the use of the aid

1.4

21.7

948

6802

S01EA03

ATC

apraclonidine; ophthalmic

3.2

21.7

271

R06AX27

ATC

desloratadine; oral

1.2

21.7

3565

30523

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

21.7

3099

26155

J31.0

ICD-10 Finland

Chronic rhinitis

1.4

21.6

893

6342

S01EE03

ATC

bimatoprost; ophthalmic

2.3

21.6

166

732

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.4

21.5

847

5964

M25.5

ICD-10 Finland

Pain in joint

1.2

21.5

3531

30227

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

2.7

21.4

115

429

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.2

21.4

3474

29702

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.1

21.3

205

988

ZXE20

NOMESCO Finland

More than three and less than five hours

1.4

21.3

1180

8807

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

2.5

21.3

134

540

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.4

21.3

886

6302

H02.3

ICD-10 Finland

Blepharochalasis

1.6

21.2

507

3214

R06AE07

ATC

cetirizine; oral

1.2

21.1

5220

46427

H40.10

ICD-10 Finland

Capsular glaucoma with pseudoexfoliation on the anterior lens capsule

2.2

21.1

167

746

G43.3

ICD-10 Finland

Complicated migraine

2.0

20.9

222

1110

M03BX02

ATC

tizanidine; oral

1.2

20.9

7082

64731

G43.9

ICD-10 Finland

Migraine, unspecified

1.5

20.9

762

5289

N06AA09

ATC

amitriptyline; systemic

1.5

20.9

782

5455

H17.1

ICD-10 Finland

Other central corneal opacity

5.7

20.9

S01FA01

ATC

atropine; ophthalmic

4.4

20.8

119

R03DC03

ATC

montelukast; oral

1.3

20.8

1812

14423

R13

ICD-10 Finland

Dysphagia

1.5

20.6

572

3753

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.6

20.6

460

2870

S01EE04

ATC

travoprost; ophthalmic

2.4

20.5

141

592

3504

FHL

Retroposition of two muscles

209.5

20.5

H54.3

ICD-10 Finland

Mild or no visual impairment, binocular

4.9

20.5

CG2Z4

NOMESCO Finland

Specialised imaging of cornea

6.3

20.4

H27.8

ICD-10 Finland

Other specified disorders of lens

6.3

20.4

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.5

20.4

691

4727

H46

ICD-10 Finland

Optic neuritis

2.6

20.3

112

424

Q12.0

ICD-10 Finland

Congenital cataract

7.4

20.2

CS3P4

NOMESCO Finland

Optic nerve head stereophotography

2.9

20.2

325

CKD10

NOMESCO Finland

Insufflation of vitreous cavity

2.3

20.2

144

615

L03AX13

ATC

glatiramer acetate; parenteral

3.4

20.2

208

H53.8

ICD-10 Finland

Other visual disturbances

2.4

20.1

137

573

S01EC54

ATC

brinzolamide, combinations; ophthalmic

2.8

20.1

101

364

R01AD12

ATC

fluticasone furoate; nasal

1.2

20.1

3825

33167

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

20.1

924

6687

CHD65

NOMESCO Finland

Nonpenetrating glaucoma surgery

3.4

19.9

200

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

19.9

697

4800

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

19.9

1815

14531

F28

ICPC

Limited function/disability (F)

3.3

19.8

215

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.7

19.8

374

2237

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.4

19.7

1081

8055

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

2.5

19.6

124

502

M41.4

ICD-10 Finland

Neuromuscular scoliosis

6.4

19.5

CHW99

NOMESCO Finland

Other operation on anterior chamber, anterior chamber angle, iris or ciliary body

21.5

19.4

J01DB01

ATC

cefalexin; oral

1.2

19.4

10202

96605

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

3.1

19.4

264

SPAT1153

SPAT

Removal of sutures

1.2

19.3

2887

24428

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.5

19.3

551

3638

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.4

19.2

737

5164

R02

ICPC

Shortness of breath/dyspnoea

1.3

19.2

1197

9095

CKD93

NOMESCO Finland

Extended combined procedure on vitreous body and retina

3.9

19.2

140

C09CA06

ATC

candesartan; oral

1.3

19.1

2193

18031

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

19.1

1978

16070

H26.9

ICD-10 Finland

Cataract, unspecified

2.4

19.1

129

538

A02BA02

ATC

ranitidine; systemic

1.3

19.0

1544

12171

H26.3

ICD-10 Finland

Drug-induced cataract

3.3

19.0

216

F71.0

ICD-10 Finland

Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour

6.7

19.0

G80.1

ICD-10 Finland

Spastic diplegic cerebral palsy

6.9

19.0

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.5

18.9

577

3865

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

2.4

18.9

125

517

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.5

18.8

536

3539

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

3.2

18.8

238

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.5

18.7

508

3316

H27.1

ICD-10 Finland

Dislocation of lens

4.6

18.7

A02BC01

ATC

omeprazole; systemic

1.2

18.7

2558

21436

3781A

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Divergent concomitant strabismus[STRABISMUS CONCOMITANS DIVERGENS]

+∞

18.7

ZY010

NOMESCO Finland

Hospital outpatient

1.5

18.7

636

4353

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.4

18.7

848

6122

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

18.7

4613

40890

N03AG04

ATC

vigabatrin; oral

5.8

18.7

S01AX11

ATC

[U] ofloxacin

1.8

18.6

280

1570

CHD35

NOMESCO Finland

Laser goniopuncture

4.3

18.6

109

A06AD11

ATC

lactulose; oral

1.4

18.6

1071

8042

S01BC03

ATC

diclofenac; ophthalmic

2.0

18.5

190

939

R50.9

ICD-10 Finland

Fever, unspecified

1.3

18.5

1552

12283

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.4

18.5

799

5721

RT274, ,

NOMESCO Finland

5.1

18.5

CG2S4

NOMESCO Finland

Photography of cornea

4.1

18.4

118

L04AD01

ATC

ciclosporin; systemic

2.0

18.4

196

982

SPAT1310

SPAT

Counselling related to known health issue

1.2

18.4

3470

30020

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.6

18.4

433

2738

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.4

18.4

1036

7752

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

18.4

2324

19313

DFF20

NOMESCO Finland

Audiometry for children

3.8

18.3

145

109

Kela drug reimbursment

Multiple sclerosis

2.3

18.3

142

630

R51

ICD-10 Finland

Headache

1.5

18.3

646

4457

181

Kela drug reimbursment

Retigabine and vigabatrin

6.4

18.2

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

18.2

682

4757

CKD40

NOMESCO Finland

Endophotocoagulation of retina

2.4

18.2

118

484

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

18.2

1154

8791

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.9

18.1

220

1153

S18

ICPC

Laceration/cut

1.2

18.1

4549

40350

J01FA10

ATC

azithromycin; systemic

1.2

18.1

7297

67296

R05

ICD-10 Finland

Cough

1.2

18.0

2190

18114

R01AD58

ATC

fluticasone, combinations; nasal

1.2

18.0

2922

24907

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

2.3

17.9

135

591

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.4

17.9

937

6926

R03BA05

ATC

fluticasone; inhalant

1.3

17.9

1989

16284

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.5

17.8

634

4378

G04CA01

ATC

alfuzosin; oral

1.4

17.8

761

5437

M79.1

ICD-10 Finland

Myalgia

1.3

17.8

1529

12139

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.6

17.8

388

2409

J05AB01

ATC

aciclovir; systemic

1.2

17.7

2167

17933

J01MA02

ATC

ciprofloxacin; systemic

1.2

17.7

3612

31448

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.3

17.7

1129

8604

37929

ICD-8 Finland

Blindness, one eye, specifically defined

22.7

17.7

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.0

17.7

197

1004

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.5

17.6

481

3147

WX400

NOMESCO Finland

Inhalation anesthesy

1.6

17.6

459

2972

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

3.8

17.5

136

H93.1

ICD-10 Finland

Tinnitus

1.5

17.4

619

4274

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

17.4

1909

15607

F45.8

ICD-10 Finland

Other somatoform disorders

1.4

17.4

833

6072

CE2W4

NOMESCO Finland

Eye movement mapping

7.7

17.3

3610A

ICD-9 Finland

Retinal detachments and defects, Retinal detachment with retinal defect

5.1

17.3

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

17.2

892

6583

AA5HE

NOMESCO Finland

Brain ultrasound examination in a child

3.1

17.2

230

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.4

17.1

835

6105

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

17.0

3186

27501

M54.5

ICD-10 Finland

Low back pain

1.2

16.9

3910

34388

R06.5

ICD-10 Finland

Mouth breathing

1.4

16.9

867

6389

101

Kela drug reimbursment

Anterior pituitary hypofunction

2.7

16.8

342

N17

ICPC

Vertigo/dizziness

1.3

16.8

1069

8142

SPAT1312

SPAT

General health counselling

1.2

16.8

3717

32567

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

16.8

4566

40708

T85.2

ICD-10 Finland

Mechanical complication of intraocular lens

4.3

16.7

101

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.2

16.7

2821

24113

N06AB06

ATC

sertraline; oral

1.3

16.6

1259

9824

3783A

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Other and unspecified heterotropia

+∞

16.6

WX892

NOMESCO Finland

Monitored bed care

1.4

16.6

624

4355

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.5

16.6

479

3171

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

16.6

4077

36034

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.3

16.5

998

7542

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

2.8

16.5

289

M03BX01

ATC

baclofen; systemic

2.0

16.5

172

857

CJA00

NOMESCO Finland

Implantation of phakic lens in anterior chamber

169.5

16.5

F70.1

ICD-10 Finland

Mild mental retardation, Significant impairment of behaviour requiring attention or treatment

4.4

16.4

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.3

16.3

1333

10505

R5210

NOMESCO Finland

Assessment of the improvements needed in the living environment

5.1

16.3

FM2CE, ,

NOMESCO Finland

2.4

16.3

114

484

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.0

16.2

171

855

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.6

16.2

368

2307

SAA04

NOMESCO Finland

Special examination of mouth

1.4

16.2

620

4345

TPH07

NOMESCO Finland

Cathetrisation of artery

1.4

16.1

884

6584

L04AA06

ATC

mycophenolic acid; systemic

1.9

16.1

188

974

H16.9

ICD-10 Finland

Keratitis, unspecified

2.0

16.1

174

878

G40.4

ICD-10 Finland

Other generalized epilepsy and epileptic syndromes

4.0

16.0

113

SPAT1325

SPAT

Vaccination

1.2

16.0

3264

28366

K59.09

ICD-10 Finland

Constipation, unspecified

1.5

16.0

534

3642

D07AC01

ATC

betamethasone; topical

1.2

16.0

3625

31795

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

15.9

6318

57943

S06.0

ICD-10 Finland

Concussion

1.3

15.9

1104

8515

F51.0

ICD-10 Finland

Nonorganic insomnia

1.2

15.8

1800

14760

G04BD08

ATC

solifenacin; oral

1.5

15.8

459

3042

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.3

15.8

1274

10021

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

1.9

15.8

210

1135

K59.0

ICD-10 Finland

Constipation

1.5

15.8

477

3190

J01CA04

ATC

amoxicillin; systemic

1.2

15.8

10563

100881

RT490, ,

NOMESCO Finland

6.3

15.7

CEC20

NOMESCO Finland

Recession and advancement of extraocular muscle

+∞

15.6

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

15.6

4390

39190

J45

ICD-10 Finland

Asthma

1.3

15.5

1035

7938

127

Kela drug reimbursment

Transplant complication

2.0

15.5

159

788

3716A

ICD-9 Finland

Corneal opacity and other disorders of cornea, Keratoconus

21.9

15.5

N06AB10

ATC

escitalopram; oral

1.2

15.5

2398

20310

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

15.4

6555

60358

R52.9

ICD-10 Finland

Pain, unspecified

1.3

15.4

935

7072

R11

ICD-10 Finland

Nausea and vomiting

1.4

15.3

865

6472

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.4

15.3

809

5991

J45.9

ICD-10 Finland

Asthma, unspecified

1.2

15.2

1835

15140

A03FA01

ATC

metoclopramide; systemic, rectal

1.2

15.1

2059

17213

Q85.00

ICD-10 Finland

Neurofibromatosis, type 1

4.8

15.1

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

15.1

2994

25940

N06AX12

ATC

bupropion; oral

1.4

15.0

832

6205

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

1.9

15.0

195

1047

H53

ICD-10 Finland

Visual disturbances

2.5

15.0

380

N03AF01

ATC

carbamazepine; oral, rectal

1.6

15.0

385

2485

R03AK07

ATC

formoterol and budesonide; inhalant

1.2

15.0

2157

18127

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.3

14.9

1066

8250

M54.4

ICD-10 Finland

Lumbago with sciatica

1.2

14.8

1741

14320

R52.2

ICD-10 Finland

Other chronic pain

1.6

14.8

326

2029

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.2

14.8

1799

14851

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.6

14.8

336

2109

WX780

NOMESCO Finland

Remote monitoring CPAP

1.6

14.8

379

2447

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

2.5

14.7

342

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

14.7

743

5463

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.3

14.7

1320

10527

N06AX26

ATC

vortioxetine; oral

1.4

14.7

809

6030

H01

ICPC

Ear pain/earache

1.3

14.6

1394

11195

M01AE02

ATC

naproxen; oral, rectal

1.2

14.6

6750

62426

CEC90

NOMESCO Finland

Total transposition of extraocular muscle or muscles

+∞

14.6

CEC50

NOMESCO Finland

Advancement of extraocular muscle

+∞

14.6

H50.6

ICD-10 Finland

Mechanical strabismus

+∞

14.6

3673A

ICD-9 Finland

Disorders of refraction and accommodation, Anisometropia and aniseikonia

+∞

14.6

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

2.6

14.5

321

WX720

NOMESCO Finland

Own respiration

1.5

14.5

411

2712

JN3AD

NOMESCO Finland

Abdominal CT examination

1.3

14.5

961

7362

L01

ICPC

Neck symptom/complaint

1.2

14.5

1620

13254

BE00A, ,

NOMESCO Finland

14.1

14.5

R01AD01

ATC

beclometasone; nasal

1.3

14.4

1446

11686

G80.2

ICD-10 Finland

Spastic hemiplegic cerebral palsy

5.4

14.4

C07AB02

ATC

metoprolol; systemic

1.3

14.4

1404

11310

M79.7

ICD-10 Finland

Fibromyalgia

1.6

14.3

349

2228

L03

ICPC

Low back symptom/complaint

1.2

14.3

2939

25527

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.3

14.2

1009

7801

J01FF01

ATC

clindamycin; systemic

1.2

14.2

2648

22802

XF600

NOMESCO Finland

Bloodpressure measurement

1.4

14.1

565

3990

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.2

14.1

2035

17099

J01AA02

ATC

doxycycline; systemic

1.2

14.0

8487

79910

N06BA04

ATC

methylphenidate; oral

1.5

14.0

468

3197

H81

ICPC

Excessive ear wax

1.3

14.0

1312

10518

H35.1

ICD-10 Finland

Retinopathy of prematurity

6.6

13.9

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.4

13.9

735

5441

OAB50, ,

SPAT

1.5

13.9

444

3005

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

1.8

13.9

222

1271

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.3

13.9

965

7442

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.4

13.8

582

4148

WX702

NOMESCO Finland

Supraglottic ventilation device

1.4

13.8

526

3682

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.3

13.8

1202

9545

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.2

13.8

119

553

L04AX03

ATC

methotrexate; systemic

1.3

13.8

901

6888

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.3

13.8

1128

8890

L04AA01

ATC

[U] ciclosporin

2.1

13.8

122

573

N02BF01

ATC

gabapentin; oral

1.4

13.8

712

5255

R03BA02

ATC

budesonide; inhalant

1.2

13.7

1807

15037

H20.1

ICD-10 Finland

Chronic iridocyclitis

2.2

13.7

107

477

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.8

13.7

203

1136

F95

ICPC

Strabismus

11.3

13.7

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

13.7

4106

36737

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.5

13.7

452

3079

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

1.8

13.6

214

1219

G81.9

ICD-10 Finland

Hemiplegia, unspecified

2.4

13.6

386

C01CA24

ATC

epinephrine; parenteral

1.4

13.5

694

5114

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.3

13.5

775

5810

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

2.0

13.5

136

670

M48.0

ICD-10 Finland

Spinal stenosis

1.3

13.5

818

6187

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.4

13.4

513

3594

3604

FHL

Penetration of the cornea

18.1

13.3

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.4

13.3

627

4558

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.4

13.3

741

5533

Z87.6

ICD-10 Finland

Personal history of certain conditions arising in the perinatal period

2.4

13.3

390

G04BD04

ATC

oxybutynin; oral, transdermal

1.5

13.3

371

2442

U04

ICPC

Incontinence urine

1.5

13.3

360

2355

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.4

13.2

506

3546

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.3

13.2

939

7262

N99

ICPC

Neurological disease other

2.3

13.2

101

447

J05AB11

ATC

valaciclovir; oral

1.3

13.2

1345

10883

H27.0

ICD-10 Finland

Aphakia

4.7

13.2

H26.01

ICD-10 Finland

Infantile, juvenile and presenile cataract

5.3

13.1

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.2

13.1

2120

17997

J20

ICD-10 Finland

Acute bronchitis

1.3

13.1

958

7437

H50

ICD-10 Finland

Other strabismus

39.8

13.1

R03BA08

ATC

ciclesonide; inhalant

1.3

13.1

809

6134

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.3

13.1

1109

8777

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.4

13.1

735

5496

CGG99

NOMESCO Finland

Other reconstructive operations on cornea and sclera

15.0

13.0

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

13.0

1139

9050

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

2.6

13.0

269

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

1.7

13.0

220

1281

M54.6

ICD-10 Finland

Pain in thoracic spine

1.4

12.9

719

5366

N04.80

ICD-10 Finland

Congenital nephrotic syndrome of the Finnish type

10.9

12.9

XX4AW, ,

NOMESCO Finland

3.0

12.9

182

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.4

12.9

597

4325

XCW10

NOMESCO Finland

Assessment of vision

2.2

12.9

106

483

CKD60

NOMESCO Finland

Anterior vitrectomy

3.0

12.9

177

N06AB05

ATC

paroxetine; oral

1.4

12.9

553

3956

WZC00

NOMESCO Finland

Treatment plan or consultation

1.2

12.9

4027

36106

L04AA31

ATC

[U] teriflunomide

3.4

12.9

132

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.4

12.9

518

3665

SPAT1211

SPAT

Application of soft bandage

1.3

12.9

841

6430

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

1.9

12.8

163

871

37003

ICD-8 Finland

Refractive errors, Anisometropia

49.8

12.8

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.2

12.8

3955

35426

Z94.0

ICD-10 Finland

Kidney transplant status

2.2

12.8

110

511

CJF30

NOMESCO Finland

Reduction of dislocation of artificial lens

5.0

12.8

CKC70

NOMESCO Finland

Circular buckling of sclera

3.9

12.8

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.6

12.8

288

1806

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

4.5

12.7

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

12.7

3350

29645

NH3EA

NOMESCO Finland

Feet X-ray examination with load

1.8

12.7

177

974

Q85.1

ICD-10 Finland

Tuberous sclerosis

14.0

12.7

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

1.5

12.7

386

2588

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

12.6

2833

24748

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.4

12.6

482

3378

N06AB03

ATC

fluoxetine; oral

1.3

12.6

1208

9704

CD2S4

NOMESCO Finland

Photography of eye

2.8

12.6

212

N06AX05

ATC

trazodone; oral

1.7

12.6

237

1421

3007

Kela drug reimbursment

Erenumab and fremanezumab

1.9

12.6

144

744

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

2.6

12.5

286

J01FA09

ATC

clarithromycin; systemic

1.2

12.5

3370

29865

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.6

12.5

298

1894

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.2

12.5

3067

26984

3505

FHL

Single muscle resection

+∞

12.5

H51.8

ICD-10 Finland

Other specified disorders of binocular movement

+∞

12.5

F84.9

ICD-10 Finland

Pervasive developmental disorder, unspecified

3.1

12.5

160

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.5

12.4

390

2631

RS221, ,

NOMESCO Finland

1.9

12.4

142

733

301

Kela drug reimbursment

Growth hormone

3.7

12.4

102

ZYC01

NOMESCO Finland

Remote contact by phone

1.4

12.4

582

4229

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.5

12.4

365

2431

K30

ICD-10 Finland

Functional dyspepsia

1.3

12.3

1058

8384

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

1.9

12.3

141

729

DFF00

NOMESCO Finland

Pure tone audiometry

1.3

12.3

768

5835

XF404

NOMESCO Finland

Ambulatory ECG

1.4

12.3

675

5031

N01

ICPC

Headache

1.2

12.3

1520

12564

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

1.8

12.2

169

928

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

2.4

12.2

326

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.4

12.2

547

3947

F84.5

ICD-10 Finland

Asperger syndrome

2.2

12.1

438

A03FA02

ATC

cisapride; oral, rectal

1.4

12.1

573

4171

Q21.10

ICD-10 Finland

Persistent ostium secundum

2.5

12.1

303

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.2

12.1

1352

11054

N02CC04

ATC

rizatriptan; oral

1.4

12.1

593

4342

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.2

12.0

2797

24488

CJ2M4

NOMESCO Finland

Scans and measurement printouts for intraocular lens power calculation

2.5

12.0

298

L01BA01

ATC

methotrexate; systemic

1.6

12.0

308

1993

SAA01

NOMESCO Finland

Simple examination of mouth

1.1

12.0

9090

86394

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

2.4

11.9

347

H02AB04

ATC

methylprednisolone; systemic

1.2

11.9

1258

10215

G40.10

ICD-10 Finland

Simple partial seizures

2.5

11.9

293

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

2.6

11.9

270

SPAT1097

SPAT

Recording of ECG

1.3

11.9

1090

8711

A11

ICPC

Chest pain NOS

1.4

11.9

638

4739

CA1ME

NOMESCO Finland

Ultrasound oculometry

3.0

11.9

165

SPAT1229

SPAT

Assessment of need for aid

1.4

11.8

508

3636

CKD70

NOMESCO Finland

Excision of preretinal or epiretinal membrane

2.1

11.8

109

521

K59.1

ICD-10 Finland

Functional diarrhoea

1.4

11.8

469

3311

G56.2

ICD-10 Finland

Lesion of ulnar nerve

1.6

11.8

286

1825

D01

ICPC

Abdominal pain/cramps general

1.2

11.8

1333

10908

SPAT1262

SPAT

Handing over of treatment supplies

1.2

11.8

1379

11326

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.5

11.8

386

2629

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.4

11.8

545

3953

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

1.7

11.7

203

1190

C07AB07

ATC

bisoprolol; oral

1.2

11.7

3917

35236

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.5

11.7

404

2779

L03AB07

ATC

interferon beta-1a; parenteral

2.5

11.7

278

M35.7

ICD-10 Finland

Hypermobility syndrome

1.8

11.7

167

927

L28

ICPC

Limited function/disability (L)

1.2

11.7

1287

10505

N02CD01

ATC

erenumab; parenteral

2.2

11.7

100

465

N05CD07

ATC

temazepam; oral

1.3

11.6

760

5810

RL130, ,

NOMESCO Finland

3.2

11.6

141

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.4

11.6

492

3514

Z83.5

ICD-10 Finland

Family history of eye and ear disorders

4.3

11.6

H40.9

ICD-10 Finland

Glaucoma, unspecified

2.1

11.5

107

513

L08

ICPC

Shoulder symptom/complaint

1.2

11.5

1979

16882

G03DB01

ATC

dydrogesterone; oral

1.2

11.5

1274

10403

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.3

11.5

799

6164

A04

ICPC

Weakness/tiredness general

1.2

11.4

1494

12414

ZXD05

NOMESCO Finland

Urgent procedure

1.2

11.4

3009

26592

R01AD08

ATC

fluticasone; nasal

1.2

11.4

3025

26748

N03AX18

ATC

lacosamide; systemic

2.4

11.4

330

S01AD03

ATC

aciclovir; ophthalmic

1.6

11.4

288

1858

N18.8

ICD-10 Finland

Other chronic renal failure

1.8

11.4

158

870

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.2

11.3

1229

10010

SPAT1009

SPAT

Measurement of intraocular pressure

2.1

11.3

105

503

S29

ICPC

Skin symptom/complaint other

1.2

11.3

1815

15385

C08CA01

ATC

amlodipine; oral

1.2

11.3

2872

25308

XQ800

NOMESCO Finland

Prick test

1.3

11.3

822

6380

WX723

NOMESCO Finland

CPAP therapy

1.5

11.3

344

2310

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.3

11.3

984

7816

WX725

NOMESCO Finland

Noninvasive ventilation

1.4

11.3

455

3224

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.2

11.2

1241

10131

H35.36

ICD-10 Finland

Macular cyst

2.7

11.2

220

P01BA02

ATC

hydroxychloroquine; oral

1.3

11.2

708

5388

XKD03

NOMESCO Finland

Urethral pressure profilometry

1.8

11.2

158

874

KMAK, ,

NOMESCO Finland

1.1

11.2

5877

54430

K00.40

ICD-10 Finland

Postnatal enamel hypoplasia

1.9

11.2

127

655

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.5

11.1

379

2601

XCD20

NOMESCO Finland

Photoangiography of eye

2.1

11.1

107

520

AA3AD

NOMESCO Finland

CT of face

2.5

11.1

279

H40.22

ICD-10 Finland

Chronic glaucoma with closed ventricular angle

2.8

11.1

193

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

11.1

329

2195

Z99.2

ICD-10 Finland

Dependence on renal dialysis

4.9

11.1

RT271, ,

NOMESCO Finland

4.0

11.1

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.4

11.1

437

3082

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

1.9

11.1

141

755

Q10.0

ICD-10 Finland

Congenital ptosis

5.5

11.1

N02CC06

ATC

eletriptan; oral

1.5

11.1

378

2595

WX704

NOMESCO Finland

Intubation

1.3

11.1

721

5510

N02BF02

ATC

pregabalin; oral

1.4

11.0

504

3647

R4130

NOMESCO Finland

Speech therapy

1.7

11.0

202

1205

CJF50

NOMESCO Finland

Removal and implantation of artificial lens in posterior chamber

11.1

11.0

C10AC01

ATC

colestyramine; oral

1.6

11.0

223

1366

S01EC03

ATC

dorzolamide; ophthalmic

2.3

10.9

361

K03.00

ICD-10 Finland

Approximal wear

1.3

10.9

679

5156

G04CA02

ATC

tamsulosin; oral

1.2

10.9

1322

10897

N88

ICPC

Epilepsy

2.5

10.9

258

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

3.5

10.9

102

37103

ICD-8 Finland

Corneal opacity, Keratoconus

43.2

10.9

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

1.7

10.9

196

1163

H33.1

ICD-10 Finland

Retinoschisis and retinal cysts

2.8

10.9

190

N05AX08

ATC

risperidone; systemic

1.3

10.9

647

4882

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

1.6

10.9

233

1446

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

10.9

2296

19931

N31.0

ICD-10 Finland

Uninhibited neuropathic bladder, not elsewhere classified

3.4

10.8

112

N86

ICPC

Multiple sclerosis

2.5

10.8

253

N05AH03

ATC

olanzapine; systemic

1.3

10.8

601

4487

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.2

10.8

2443

21318

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

10.8

993

7934

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.0

10.8

107

526

L04AA13

ATC

[U] leflunomide

1.7

10.8

205

1235

N04BB01

ATC

amantadine; oral

2.0

10.8

117

595

H66.9

ICD-10 Finland

Otitis media, unspecified

1.3

10.8

844

6615

L03AB08

ATC

interferon beta-1b; parenteral

3.3

10.7

118

H18.4

ICD-10 Finland

Corneal degeneration

2.9

10.7

170

X58

ICD-10 Finland

Exposure to other specified factors

1.2

10.7

1443

12028

S01XA18

ATC

ciclosporin; ophthalmic

2.4

10.7

285

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

1.6

10.7

238

1492

3744

FHL

Pericardial identification surgery with coagulation (includes epi- and intrascleral indications and eg Lincoff catheter)

5.5

10.6

H50.4

ICD-10 Finland

Other and unspecified heterotropia

59.8

10.6

J01FA06

ATC

roxithromycin; oral

1.1

10.6

3862

34900

353

Kela drug reimbursment

Cladribine and fingolimod

3.1

10.6

134

G04BD07

ATC

tolterodine; oral

1.5

10.6

295

1945

N29

ICPC

Neurological sympt/complt other

1.8

10.6

150

832

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.3

10.5

718

5523

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.3

10.5

911

7228

EJC20

NOMESCO Finland

Operation on frenulum of tongue

2.7

10.5

199

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

1.7

10.5

170

980

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

1.6

10.5

249

1584

G50.1

ICD-10 Finland

Atypical facial pain

1.8

10.5

153

856

N05AX12

ATC

aripiprazole; systemic

1.4

10.5

444

3174

-1, ,

NOMESCO Finland

1.1

10.5

4052

36757

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.4

10.5

474

3427

WX882

NOMESCO Finland

High dependency care

1.6

10.4

258

1656

G80.0

ICD-10 Finland

Spastic quadriplegic cerebral palsy

9.1

10.4

RK220, ,

NOMESCO Finland

2.9

10.4

156

R06AX22

ATC

ebastine; oral

1.2

10.4

1705

14470

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.2

10.4

1260

10383

B07.9

ICD-10 Finland

Verruca simplex

1.5

10.4

363

2504

A02BC04

ATC

rabeprazole; oral

1.3

10.4

768

5972

F70.9

ICD-10 Finland

Mild mental retardation, Without mention of impairment of behaviour

4.0

10.4

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.2

10.4

1924

16512

164

Kela drug reimbursment

Fingolimod

3.0

10.4

146

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

2.4

10.4

301

F01

ICPC

Eye pain

1.5

10.4

287

1890

RT150, ,

NOMESCO Finland

2.8

10.4

173

H47.1

ICD-10 Finland

Papilloedema, unspecified

2.5

10.3

247

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.3

10.3

663

5060

RS110, ,

NOMESCO Finland

3.2

10.3

121

M01AH01

ATC

celecoxib; oral

1.2

10.3

1445

12089

37600

ICD-8 Finland

Detachment of retina, Primaria

8.1

10.3

F93.89

ICD-10 Finland

Other childhood emotional disorders

1.9

10.2

130

698

H92.0

ICD-10 Finland

Otalgia

1.3

10.2

645

4912

Z01.9

ICD-10 Finland

Special examination, unspecified

1.4

10.2

495

3622

R06.4

ICD-10 Finland

Hyperventilation

1.8

10.2

156

886

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.3

10.2

832

6557

A01

ICPC

Pain general/multiple sites

1.3

10.1

788

6170

J01MA06

ATC

norfloxacin; oral

1.2

10.1

1053

8538

XFE00

NOMESCO Finland

Epicardial ultrasonography

1.8

10.1

149

837

N02CC03

ATC

zolmitriptan; nasal, oral

1.4

10.1

541

4020

RS220, ,

NOMESCO Finland

1.9

10.1

125

665

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.5

10.1

318

2152

H47.3

ICD-10 Finland

Other disorders of optic disc

2.9

10.0

149

J01EA01

ATC

trimethoprim; systemic

1.2

10.0

2500

21974

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.5

10.0

354

2449

H61.2

ICD-10 Finland

Impacted cerumen

1.4

10.0

528

3914

G40.89

ICD-10 Finland

Other epilepsy

2.7

10.0

199

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.0

10.0

481

E03

ICD-10 Finland

Other hypothyroidism

1.4

9.9

511

3772

CK2L4

NOMESCO Finland

Wide-field/panoramic imaging of ocular fundus

2.4

9.9

270

H60.8

ICD-10 Finland

Other otitis externa

1.5

9.9

274

1803

CM2S4

NOMESCO Finland

Follow-up photography of age-related macular degeneration lesions

2.8

9.9

177

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

1.8

9.9

151

856

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

2.2

9.9

345

L57.0

ICD-10 Finland

Actinic keratosis

1.3

9.9

603

4567

XF402

NOMESCO Finland

ECG with work load test

1.3

9.9

733

5703

H54.6

ICD-10 Finland

Moderate visual impairment, monocular

3.4

9.9

104

RS311, ,

NOMESCO Finland

3.2

9.9

114

R03BA01

ATC

beclometasone; inhalant

1.2

9.9

1223

10102

D02

ICPC

Abdominal pain epigastric

1.3

9.9

572

4300

J01MA12

ATC

levofloxacin; systemic

1.2

9.9

1442

12108

Congenital heart failure surgery

3.8

9.8

G80.9

ICD-10 Finland

Cerebral palsy, unspecified

7.6

9.8

M54.2

ICD-10 Finland

Cervicalgia

1.3

9.8

728

5666

H26.8

ICD-10 Finland

Other specified cataract

2.4

9.8

284

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

1.8

9.8

150

852

M02AA07

ATC

piroxicam; topical

1.1

9.8

3059

27331

T78.4

ICD-10 Finland

Allergy, unspecified

1.4

9.8

490

3604

R60.0

ICD-10 Finland

Localized oedema

1.3

9.8

916

7340

P29

ICPC

Psychological sympt/compl other

1.3

9.7

842

6681

M08.4

ICD-10 Finland

Pauciarticular juvenile arthritis

2.2

9.7

354

F72.0

ICD-10 Finland

Severe mental retardation, with the statement of no, or minimal, impairment of behaviour

10.6

9.7

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.3

9.7

889

7101

WYA10

NOMESCO Finland

Emergency care or similar visit

1.3

9.7

770

6043

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

1.9

9.7

121

645

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.4

9.7

492

3624

J45.1

ICD-10 Finland

Nonallergic asthma

1.3

9.7

652

5008

NG1DA

NOMESCO Finland

X-ray of knees

1.8

9.7

131

717

E000001, ,

ATC

1.2

9.7

2075

18020

XCH05

NOMESCO Finland

Eye pressure longterm registration

2.3

9.7

292

G44.0

ICD-10 Finland

Cluster headache syndrome

1.9

9.7

111

576

RT190, ,

NOMESCO Finland

7.3

9.6

S01BC05

ATC

ketorolac; ophthalmic

1.6

9.6

215

1350

R1250

NOMESCO Finland

Evaluation of functional capability

1.7

9.6

184

1112

B03XA01

ATC

erythropoietin; parenteral

2.4

9.6

269

Q99.8

ICD-10 Finland

Other specified chromosome abnormalities

4.2

9.6

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

1.9

9.5

123

663

H43.1

ICD-10 Finland

Vitreous haemorrhage

1.7

9.5

171

1015

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

2.7

9.5

181

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.1

9.5

6329

59229

N02CC07

ATC

frovatriptan; oral

1.4

9.5

424

3060

R03AC03

ATC

terbutaline; inhalant

1.2

9.5

1309

10930

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.1

9.5

6451

60447

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.1

9.5

5419

50270

R32

ICD-10 Finland

Unspecified urinary incontinence

1.6

9.5

194

1192

R03AK08

ATC

formoterol and beclometasone; inhalant

1.4

9.5

366

2576

S01BA01

ATC

dexamethasone; ophthalmic

1.5

9.5

263

1735

H02AB07

ATC

prednisone; oral

1.2

9.5

1106

9082

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

1.8

9.4

143

810

H29

ICPC

Ear symptom/complaint other

1.2

9.4

978

7926

VALMI, ,

NOMESCO Finland

1.1

9.4

2928

26135

K03.64

ICD-10 Finland

Dental calculus supragingival

1.1

9.4

3799

34501

G93.2

ICD-10 Finland

Benign intracranial hypertension

3.1

9.4

123

CJA10

NOMESCO Finland

Implantation of phakic lens in posterior chamber

29.9

9.4

L04AD02

ATC

tacrolimus; systemic

1.9

9.4

104

534

3602A

ICD-9 Finland

Disorders of the globe, Degenerative disorders of globe[MYOPIA MALIGNA]

+∞

9.4

3784B

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Heterophoria[EXOPHORIA]

+∞

9.4

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

2.1

9.4

386

Q25.0

ICD-10 Finland

Patent ductus arteriosus

2.9

9.3

139

S01

ICPC

Pain/tenderness of skin

1.4

9.3

389

2775

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

2.3

9.3

291

M03AX01

ATC

botulinum toxin; parenteral

1.8

9.3

139

785

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.3

9.3

659

5100

R05

ICPC

Cough

1.2

9.3

2499

22081

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.3

9.3

553

4178

F81.3

ICD-10 Finland

Mixed disorder of scholastic skills

2.4

9.2

267

H43.2

ICD-10 Finland

Crystalline deposits in vitreous body

3.7

9.2

SCD02

NOMESCO Finland

Removal of biofilm and/or supragingival calculus

2.2

9.2

349

XJH00

NOMESCO Finland

Transanal ultrasonography

1.5

9.2

307

2101

Q85.09

ICD-10 Finland

Unspecified neurofibromatosis

4.5

9.2

L16

ICPC

Ankle symptom/complaint

1.2

9.2

1174

9725

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.5

9.2

274

1834

XF602

NOMESCO Finland

Bloodpressure monitoring

2.0

9.2

503

SCA01

NOMESCO Finland

Preventive oral health care, short

1.1

9.2

3817

34724

SPAT1053

SPAT

Memory test

1.3

9.2

731

5744

L82

ICD-10 Finland

Seborrhoeic keratosis

1.2

9.1

1407

11870

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.2

9.1

2496

22071

D06

ICPC

Abdominal pain localized other

1.3

9.1

875

7028

M01AH02

ATC

rofecoxib; oral

1.3

9.1

888

7145

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.3

9.1

661

5130

U02

ICPC

Urinary frequency/urgency

1.2

9.1

1297

10862

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

9.1

309

2123

H13

ICPC

Plugged feeling ear

1.2

9.1

1520

12919

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.5

9.1

234

1518

A28

ICPC

Limited function/disability NOS

1.2

9.1

1048

8592

P01AB01

ATC

metronidazole; oral, rectal

1.1

9.1

4135

37820

H40.20

ICD-10 Finland

Acute glaucoma with closed ventricular angle

3.2

9.1

105

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

2.4

9.1

233

SAA02

NOMESCO Finland

Basic examination of mouth

1.1

9.1

8601

82031

K03.66

ICD-10 Finland

Tooth plaque

1.3

9.0

743

5859

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.2

9.0

1328

11156

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

1.6

9.0

208

1316

Z01.2

ICD-10 Finland

Dental examination

1.1

9.0

5513

51290

H19.1*B00.5

ICD-10 Finland

Herpesviral keratoconjunctivitis

2.2

9.0

333

Q87.80

ICD-10 Finland

Alport syndrome

11.4

9.0

BC00A, ,

NOMESCO Finland

8.2

9.0

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.3

9.0

849

6808

Q05.2

ICD-10 Finland

Lumbar spina bifida with hydrocephalus

15.5

9.0

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

3.5

9.0

N06AX17

ATC

milnacipran; oral

2.0

9.0

480

R39.1

ICD-10 Finland

Other difficulties with micturition

1.6

9.0

204

1287

P07.2

ICD-10 Finland

Extreme immaturity

7.0

9.0

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.3

9.0

798

6356

TKC22

NOMESCO Finland

Catheterisation instruction

1.8

9.0

137

779

RS222, ,

NOMESCO Finland

1.9

8.9

100

515

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.3

8.9

649

5039

SPAT1139

SPAT

Nutrition survey

1.5

8.9

259

1725

NF1AA

NOMESCO Finland

Hip X-ray examination

1.3

8.9

573

4376

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.5

8.9

249

1646

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.4

8.9

368

2623

3046, ,

Kela drug reimbursment

23.9

8.9

R30.0

ICD-10 Finland

Dysuria

1.4

8.8

377

2702

Z71.8

ICD-10 Finland

Other specified counselling

1.1

8.8

3447

31219

E23.00

ICD-10 Finland

Panhypopituitarism

2.9

8.8

133

N05CD08

ATC

midazolam; nasal, systemic

1.7

8.8

165

992

L12

ICPC

Hand/finger symptom/complaint

1.2

8.8

1665

14304

H17.9

ICD-10 Finland

Corneal scar and opacity, unspecified

3.7

8.8

E66.8

ICD-10 Finland

Other obesity

1.3

8.8

532

4028

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

1.9

8.8

100

519

R07.3

ICD-10 Finland

Other chest pain

1.3

8.8

827

6633

J34.2

ICD-10 Finland

Deviated nasal septum

1.4

8.8

441

3248

A05

ICPC

Feeling ill

1.3

8.7

800

6392

SDA03

NOMESCO Finland

Periodontal treatment

1.1

8.7

4438

40840

R51.81

ICD-10 Finland

Facial pain NOS

1.6

8.7

209

1337

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

1.9

8.7

493

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.4

8.7

318

2219

-44

ICPC

Preventive immunization/medic

1.3

8.6

622

4824

H02

ICPC

Hearing complaint

1.2

8.6

931

7581

CGG11

NOMESCO Finland

Corneal cross-linking

3.8

8.6

M01AH05

ATC

etoricoxib; oral

1.1

8.6

6682

62934

M08.9

ICD-10 Finland

Juvenile arthritis, unspecified

2.8

8.6

146

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

1.7

8.6

158

946

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.2

8.6

1120

9300

TJD20

NOMESCO Finland

Change of gastrostomy tube

2.8

8.5

152

Z94.4

ICD-10 Finland

Liver transplant status

2.8

8.5

152

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

1.7

8.5

147

865

F79

ICD-10 Finland

Unspecified mental retardation

10.0

8.5

RT160, ,

NOMESCO Finland

3.0

8.5

120

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

1.8

8.5

118

653

M54.1

ICD-10 Finland

Radiculopathy

1.4

8.5

322

2262

F81.8

ICD-10 Finland

Other developmental disorders of scholastic skills

2.7

8.5

164

H51.9

ICD-10 Finland

Disorder of binocular movement, unspecified

27.4

8.5

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

1.8

8.4

118

654

RS211, ,

NOMESCO Finland

2.4

8.4

229

RK110, ,

NOMESCO Finland

2.3

8.4

266

WZA90

NOMESCO Finland

Other medical or dental certificate

1.1

8.4

2559

22786

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.4

8.4

347

2473

JDB10

NOMESCO Finland

Percutaneous gastrostomy

2.0

8.4

396

137

Kela drug reimbursment

Uraemia requiring dialysis

2.1

8.4

330

R62.8

ICD-10 Finland

Other lack of expected normal physiological development

2.6

8.4

176

E000006, ,

ATC

1.3

8.4

578

4456

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

1.5

8.4

281

1927

J01DA09

ATC

[U] cefadroxil

1.1

8.4

2639

23554

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.2

8.4

1876

16335

J01DA06

ATC

[U] cefuroxime

1.2

8.4

1288

10865

N05BE01

ATC

buspirone; oral

1.5

8.4

240

1596

N89

ICPC

Migraine

1.4

8.3

433

3205

G43

ICD-10 Finland

Migraine

1.3

8.3

613

4768

3619

FHL

Other operations in this group, such as corneal refractive surgery

12.7

8.3

3768

FHL

Eye examination under general anesthesia

12.7

8.3

R04.0

ICD-10 Finland

Epistaxis

1.3

8.3

509

3860

L13

ICPC

Hip symptom/complaint

1.2

8.3

1431

12192

CGD00

NOMESCO Finland

Keratotomy for error of refraction

+∞

8.3

H50.3

ICD-10 Finland

Intermittent heterotropia

+∞

8.3

F60.9

ICD-10 Finland

Personality disorder, unspecified

1.7

8.3

131

752

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.5

8.3

220

1438

P03

ICPC

Feeling depressed

1.2

8.3

1235

10385

W19

ICD-10 Finland

Unspecified fall

1.2

8.3

841

6800

3745

FHL

Hard membrane girding, cerclage with coagulation

4.9

8.3

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.4

8.3

326

2304

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.1

8.3

4373

40300

R12

ICD-10 Finland

Heartburn

1.3

8.3

718

5704

CJF20

NOMESCO Finland

Removal of artificial lens

9.4

8.2

-31

ICPC

Medical examin/health eval partial

1.3

8.2

587

4548

R15

ICD-10 Finland

Faecal incontinence

1.6

8.2

182

1142

SPAT1254

SPAT

Administration of medicine

1.2

8.2

1407

11983

Z50.5

ICD-10 Finland

Speech therapy

1.7

8.2

138

807

R96

ICPC

Asthma

1.2

8.2

843

6828

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.2

8.2

1722

14920

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

2.3

8.2

257

E23.01

ICD-10 Finland

Isolated deficiency of growth hormone

2.9

8.2

128

C08CA05

ATC

nifedipine; systemic

1.4

8.2

393

2875

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.5

8.2

272

1865

F80.1

ICD-10 Finland

Expressive language disorder

1.9

8.2

518

D07AA02

ATC

hydrocortisone; topical

1.2

8.1

1511

12957

R00.2

ICD-10 Finland

Palpitations

1.3

8.1

723

5758

A11CC03

ATC

alfacalcidol; systemic

1.6

8.1

161

983

CKC65

NOMESCO Finland

Removal of buckling implant from sclera

6.4

8.1

A07AA02

ATC

nystatin; oral

1.4

8.1

412

3039

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.2

8.1

1130

9443

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.3

8.1

464

3486

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.3

8.1

640

5024

F81.0

ICD-10 Finland

Specific reading disorder

2.2

8.1

277

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

1.7

8.1

154

931

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.3

8.1

519

3964

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

2.7

8.1

151

N06AX03

ATC

mianserin; oral

1.4

8.1

341

2441

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.2

8.1

2001

17558

N02CD03

ATC

fremanezumab; systemic

1.9

8.1

499

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.3

8.1

757

6069

Q87.8

ICD-10 Finland

Other specified congenital malformation syndromes, not elsewhere classified

17.1

8.0

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.3

8.0

729

5821

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

1.9

8.0

102

549

CS2P4

NOMESCO Finland

Optic nerve head imaging

2.2

8.0

291

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.3

8.0

548

4222

N30.0

ICD-10 Finland

Acute cystitis

1.2

8.0

1561

13440

Q87.09

ICD-10 Finland

Other congenital malformations that mainly affect the appearance of the face

8.9

8.0

JDB00

NOMESCO Finland

Gastrostomy

3.7

8.0

N03AX24

ATC

cannabidiol; oral

21.9

8.0

H52.6

ICD-10 Finland

Other disorders of refraction

21.9

8.0

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

1.9

8.0

101

543

D02AX

ATC

Other emollients and protectives

1.4

8.0

324

2304

J01DA01

ATC

[U] cefalexin

1.1

8.0

6730

63555

HAHOM, ,

NOMESCO Finland

1.8

8.0

115

644

Y94.0

ICD-10 Finland

Accident at home

1.7

8.0

136

799

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.2

8.0

1065

8865

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

1.5

8.0

269

1850

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.3

7.9

609

4764

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

1.4

7.9

407

3008

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

1.5

7.9

251

1704

H26.1

ICD-10 Finland

Traumatic cataract

3.0

7.9

109

I95.1

ICD-10 Finland

Orthostatic hypotension

1.6

7.9

191

1224

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

2.3

7.9

261

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.4

7.9

416

3087

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.2

7.9

958

7897

H61.8

ICD-10 Finland

Other specified disorders of external ear

2.0

7.9

399

D07AC13

ATC

mometasone; topical

1.1

7.9

2762

24815

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.3

7.9

469

3546

N06AX22

ATC

agomelatine; oral

1.5

7.9

230

1537

N30.2

ICD-10 Finland

Other chronic cystitis

2.1

7.8

333

F31.8

ICD-10 Finland

Other bipolar affective disorders

1.6

7.8

189

1211

C03CA01

ATC

furosemide; systemic

1.2

7.8

1822

15908

R60.9

ICD-10 Finland

Oedema, unspecified

1.4

7.8

393

2896

Z93.1

ICD-10 Finland

Gastrostomy status

4.6

7.8

M03BC51

ATC

orphenadrine, combinations; systemic

1.1

7.8

2639

23653

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

1.5

7.8

259

1775

EG1CG

NOMESCO Finland

Extensive MRI examination of mandibular joint with high intensity magnet

2.7

7.8

154

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.2

7.8

1663

14423

S21

ICPC

Skin texture symptom/complaint

1.2

7.8

1255

10631

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

2.1

7.8

321

H54.4

ICD-10 Finland

Blindness, monocular

3.6

7.8

S01GX08

ATC

ketotifen; ophthalmic

1.3

7.8

429

3207

L04AA27

ATC

[U] fingolimod

3.0

7.8

105

B99

ICPC

Blood/lymph/spleen disease other

2.9

7.8

121

H10

ICD-10 Finland

Conjunctivitis

1.2

7.8

763

6150

L60.0

ICD-10 Finland

Ingrowing nail

1.3

7.8

417

3105

CKD15

NOMESCO Finland

Injection of vitreous substitute

2.8

7.8

132

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.5

7.8

235

1582

M01AX17

ATC

nimesulide; oral

1.2

7.7

1813

15836

R52.0

ICD-10 Finland

Acute pain

1.4

7.7

296

2083

F98.2

ICD-10 Finland

Feeding disorder of infancy and childhood

3.1

7.7

100

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

2.1

7.7

302

RD210, ,

NOMESCO Finland

1.6

7.7

188

1207

ND1CG

NOMESCO Finland

Wrist and hand extensive MRI examination with high intensity magnet

2.0

7.7

409

CBJ40

NOMESCO Finland

Resection of levator muscle of eyelid

2.4

7.7

196

P06

ICPC

Sleep disturbance

1.2

7.7

1187

10014

H60

ICD-10 Finland

Otitis externa

1.3

7.7

485

3697

WYA30, ,

SPAT

2.1

7.7

336

RT172, ,

NOMESCO Finland

4.2

7.7

H18.8

ICD-10 Finland

Other specified disorders of cornea

2.2

7.7

271

N62

ICD-10 Finland

Hypertrophy of breast

1.4

7.7

376

2761

J01CA08

ATC

pivmecillinam; oral

1.1

7.7

4360

40302

J01MA14

ATC

moxifloxacin; systemic

1.3

7.6

680

5418

Q89.7

ICD-10 Finland

Multiple congenital malformations, not elsewhere classified

7.4

7.6

NB1DG

NOMESCO Finland

Shoulder and humerus very extensive MRI examination with high intensity magnet

2.1

7.6

324

G43.8

ICD-10 Finland

Other migraine

1.6

7.6

157

970

T90.5

ICD-10 Finland

Sequelae of intracranial injury

1.9

7.6

467

L21.0

ICD-10 Finland

Seborrhoea capitis

1.9

7.6

467

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

1.8

7.6

105

581

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

1.8

7.6

109

610

S01EE51

ATC

latanoprost and netarsudil; ophthalmic

4.5

7.6

KFH00

NOMESCO Finland

Operation for undescended or ectopic testis

3.2

7.6

N02CC05

ATC

almotriptan; oral

1.4

7.6

392

2902

H25.9

ICD-10 Finland

Senile cataract, unspecified

2.0

7.6

419

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.2

7.6

759

6132

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

1.9

7.6

503

R5599

NOMESCO Finland

Other rehabilitation service

1.5

7.6

227

1526

Q85.9

ICD-10 Finland

Phakomatosis, unspecified

24.9

7.5

E70.3

ICD-10 Finland

Albinism

24.9

7.5

G45.3

ICD-10 Finland

Amaurosis fugax

1.8

7.5

115

655

K06.18

ICD-10 Finland

Another gingival hyperplasia

2.6

7.5

151

M13.9

ICD-10 Finland

Arthritis, unspecified

1.3

7.5

620

4894

TCC10

NOMESCO Finland

Probing of lacrimal canaliculus/duct

2.3

7.5

235

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

2.2

7.5

273

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

1.6

7.5

172

1089

H50.59

ICD-10 Finland

Heterophor UNS

8.8

7.5

Q93.5

ICD-10 Finland

Other deletions of part of a chromosome

8.8

7.5

F93

ICPC

Glaucoma

2.9

7.5

118

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

2.0

7.5

366

H52.7

ICD-10 Finland

Disorder of refraction, unspecified

6.1

7.5

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

1.6

7.5

178

1138

F02.89*G35

ICD-10 Finland

Dementia in multiple sclerosis

4.1

7.5

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

1.9

7.5

470

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

1.7

7.5

142

860

TCG00

NOMESCO Finland

Protection of cornea and sclera with soft lens

3.2

7.4

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.5

7.4

203

1338

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

1.9

7.4

436

N05AF03

ATC

chlorprothixene; systemic

1.5

7.4

213

1419

H66.4

ICD-10 Finland

Suppurative otitis media, unspecified

2.0

7.4

388

RT272, ,

NOMESCO Finland

2.8

7.4

130

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.3

7.4

468

3571

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

1.6

7.4

170

1079

CGF10

NOMESCO Finland

Suture of laceration of cornea

4.4

7.4

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.3

7.4

540

4202

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

1.6

7.4

180

1158

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.3

7.4

460

3503

7819X

ICD-9 Finland

Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]

2.1

7.3

289

D07XC01

ATC

betamethasone; topical

1.2

7.3

954

7921

J01AA07

ATC

tetracycline; systemic

1.2

7.3

1480

12778

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

1.9

7.3

452

CK2A4

NOMESCO Finland

Autofluorescence imaging of ocular fundus

2.7

7.3

142

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.3

7.3

629

4993

C05AA08

ATC

fluocortolone; rectal, topical

1.2

7.3

1084

9115

CBB10

NOMESCO Finland

Excision of redundant skin of eyelid

1.7

7.3

126

744

M01AG02

ATC

tolfenamic acid; oral, rectal

1.2

7.3

1412

12151

SCA02

NOMESCO Finland

Preventive oral health care

1.2

7.3

1320

11296

37302

ICD-8 Finland

Strabismus, Concomitans sursum sive deorsum vergens

+∞

7.3

E34.39

ICD-10 Finland

Short stature, not elsewhere classified

2.6

7.3

160

Q90.0

ICD-10 Finland

Trisomy 21, meiotic nondisjunction

6.8

7.2

SFA10

NOMESCO Finland

One-surface restoration

1.1

7.2

6531

61756

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.4

7.2

276

1943

D01BA02

ATC

terbinafine; oral

1.1

7.2

2160

19194

104

Kela drug reimbursment

Thyroid insufficiency

1.3

7.2

526

4089

RT171, ,

NOMESCO Finland

3.6

7.2

ZX114

NOMESCO Finland

Intramuscular

1.7

7.2

122

716

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.3

7.2

462

3531

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

3.1

7.2

H01.0

ICD-10 Finland

Blepharitis

1.3

7.2

624

4958

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.4

7.2

285

2020

H35.37

ICD-10 Finland

Macular holes

1.9

7.2

462

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.4

7.2

378

2807

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

1.8

7.2

519

J46

ICD-10 Finland

Status asthmaticus

1.5

7.2

224

1518

SJA01

NOMESCO Finland

Assesment of orthodontic treatment need

2.6

7.2

155

F80.9

ICD-10 Finland

Developmental disorder of speech and language, unspecified

2.3

7.2

234

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.4

7.2

333

2425

CFA20

NOMESCO Finland

Biopsy of conjunctiva

3.3

7.2

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

2.0

7.2

352

Z00.8

ICD-10 Finland

Other general examinations

1.2

7.2

726

5874

A07DA03

ATC

loperamide; oral

1.5

7.2

213

1430

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

2.4

7.1

185

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.3

7.1

578

4556

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.2

7.1

742

6021

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

1.8

7.1

492

UJH02

NOMESCO Finland

Anoscopy

1.4

7.1

303

2175

34301

ICD-8 Finland

Cerebral spastic infantile paralysis, Diplegia spastica

19.9

7.1

L20.0

ICD-10 Finland

Besnier prurigo

1.2

7.1

894

7399

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.5

7.1

208

1392

K08.80

ICD-10 Finland

Toothache NOS

1.2

7.1

877

7245

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.3

7.1

585

4621

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

2.0

7.1

367

D06BX01

ATC

metronidazole; topical

1.2

7.1

935

7777

A10AB04

ATC

insulin lispro; parenteral

1.4

7.1

255

1778

A01AB09

ATC

miconazole; local oral

1.2

7.1

695

5605

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

1.4

7.1

261

1828

-45

ICPC

Observ/health educat/advice/diet

1.4

7.1

253

1762

G80.8

ICD-10 Finland

Other cerebral palsy

12.0

7.0

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

2.2

7.0

268

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.3

7.0

507

3937

RS121, ,

NOMESCO Finland

2.1

7.0

301

I73.0

ICD-10 Finland

Raynaud syndrome

1.6

7.0

146

905

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.2

7.0

1294

11092

L04AB06

ATC

golimumab; parenteral

1.8

7.0

481

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.3

7.0

570

4498

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.2

7.0

1109

9384

J47

ICD-10 Finland

Bronchiectasis

1.8

7.0

105

597

B02AA02

ATC

tranexamic acid; systemic

1.2

7.0

1404

12120

R31

ICD-10 Finland

Unspecified haematuria

1.3

7.0

623

4970

H50.50

ICD-10 Finland

Alternating hyperphoria

6.9

7.0

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.3

7.0

391

2934

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.2

6.9

1435

12415

H18.9

ICD-10 Finland

Disorder of cornea, unspecified

3.8

6.9

S16

ICPC

Bruise/contusion

1.4

6.9

242

1678

E16.19

ICD-10 Finland

Other specified hypoglycaemia

2.5

6.9

170

L04AA05

ATC

[U] tacrolimus

4.3

6.9

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.4

6.9

345

2543

Q90.9

ICD-10 Finland

Down syndrome, unspecified

6.3

6.9

N05AH02

ATC

clozapine; systemic

1.6

6.9

162

1034

G70.0

ICD-10 Finland

Myasthenia gravis

2.9

6.9

102

S01EX03, ,

ATC

1.9

6.9

462

R30.1

ICD-10 Finland

Vesical tenesmus

1.6

6.9

153

964

A97

ICPC

No disease

1.2

6.9

1766

15527

KAC00

NOMESCO Finland

Nephrectomy

2.8

6.9

113

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.3

6.8

613

4891

N06AG02

ATC

moclobemide; oral

1.4

6.8

309

2241

G93.3

ICD-10 Finland

Postviral fatigue syndrome

2.2

6.8

252

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.3

6.8

377

2822

EMB15

NOMESCO Finland

Partial tonsillectomy

2.9

6.8

108

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

1.4

6.8

285

2041

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.2

6.8

1709

15001

H33

ICD-10 Finland

Retinal detachments and breaks

3.1

6.8

N07AA02

ATC

pyridostigmine; systemic

2.6

6.8

142

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

2.0

6.8

312

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.3

6.8

412

3127

S01CA03

ATC

hydrocortisone and antiinfectives; ophthalmic

1.9

6.8

401

H40.1

ICD-10 Finland

Primary open-angle glaucoma

3.2

6.8

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.3

6.8

599

4774

G81.1

ICD-10 Finland

Spastic hemiplegia

4.1

6.8

CKD20

NOMESCO Finland

Removal of vitreous body substitute

2.5

6.7

166

F43

ICPC

Eye, Other diagnostic procedure

1.6

6.7

140

868

CDW99

NOMESCO Finland

Other operation on eyeball

39.8

6.7

R06AX13

ATC

loratadine; oral

1.2

6.7

1538

13405

Q90

ICD-10 Finland

Down syndrome

16.6

6.7

D23.1

ICD-10 Finland

Benign neoplasm: Skin of eyelid, including canthus

1.4

6.7

236

1638

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

1.5

6.7

198

1328

WZC00, ,

SPAT

1.2

6.7

1015

8550

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.2

6.7

945

7908

N06AB08

ATC

fluvoxamine; oral

1.5

6.7

195

1304

H40

ICD-10 Finland

Glaucoma

2.1

6.7

300

FPK00

NOMESCO Finland

Implantation of electrocardiograph with loop recorder

2.2

6.7

222

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.2

6.7

808

6661

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.3

6.7

357

2659

ZXC50

NOMESCO Finland

Cryotherapy

1.5

6.7

168

1089

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

2.0

6.7

334

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

2.1

6.7

261

H04AA01

ATC

glucagon; nasal, parenteral

1.4

6.7

235

1632

L11

ICPC

Wrist symptom/complaint

1.2

6.7

908

7575

S04

ICPC

Lump/swelling localized

1.2

6.7

977

8207

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

2.1

6.7

281

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.2

6.7

737

6022

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.2

6.7

1184

10117

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.3

6.7

386

2911

A07EC01

ATC

sulfasalazine; oral, rectal

1.2

6.6

650

5240

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

1.7

6.6

110

643

J02AC02

ATC

itraconazole; systemic

1.2

6.6

1567

13692

Z71.9

ICD-10 Finland

Counselling, unspecified

1.3

6.6

615

4928

P05.1

ICD-10 Finland

Small for gestational age

3.2

6.6

S05.0

ICD-10 Finland

Injury of conjunctiva and corneal abrasion without mention of foreign body

1.5

6.6

180

1187

ZX199

NOMESCO Finland

Other rote

2.9

6.6

G44.1

ICD-10 Finland

Vascular headache, not elsewhere classified

2.2

6.6

249

-, ,

ICD-10 Finland

1.6

6.6

151

958

L04

ICPC

Chest symptom/complaint

1.3

6.6

530

4174

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.2

6.6

1163

9929

F32.1

ICD-10 Finland

Moderate depressive episode

1.2

6.6

651

5253

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

1.6

6.6

132

811

R03BB04

ATC

tiotropium bromide; inhalant

1.3

6.6

628

5047

M02AA10

ATC

ketoprofen; topical

1.2

6.6

1262

10848

N05BA12

ATC

alprazolam; oral

1.2

6.6

807

6663

3650A

ICD-9 Finland

Glaucoma, Borderline glaucoma [glaucoma suspect][SUSPICIO GLAUCOMATIS (AVOKULMA)]

3.7

6.6

H26.00

ICD-10 Finland

Infantile, juvenile and presenile cataract

7.8

6.6

A01AB04

ATC

amphotericin B; local oral

1.4

6.6

288

2079

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

2.1

6.6

289

SBB10

NOMESCO Finland

Dental impressions

1.2

6.6

861

7156

L50.9

ICD-10 Finland

Urticaria, unspecified

1.3

6.6

366

2744

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

1.4

6.6

241

1687

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

2.1

6.6

263

D02AE01

ATC

carbamide; topical

1.3

6.6

543

4294

D10AF01

ATC

clindamycin; topical

1.3

6.6

416

3178

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

1.9

6.5

413

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.1

6.5

2091

18658

L14

ICPC

Leg/thigh symptom/complaint

1.2

6.5

645

5205

U05

ICPC

Urination problems other

1.4

6.5

321

2361

S51.8

ICD-10 Finland

Open wound of other parts of forearm

1.8

6.5

463

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.2

6.5

1188

10170

CGD40

NOMESCO Finland

Implantation of intracorneal ring segments

8.6

6.5

G41.9

ICD-10 Finland

Status epilepticus, unspecified

2.4

6.5

175

B34.9

ICD-10 Finland

Viral infection, unspecified

1.4

6.5

314

2303

N03AF03

ATC

rufinamide; oral

10.0

6.5

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.3

6.5

358

2680

M54

ICD-10 Finland

Dorsalgia

1.2

6.5

1208

10360

I89.9

ICD-10 Finland

Noninfective disorder of lymphatic vessels and lymph nodes, unspecified

4.1

6.5

Q21.11

ICD-10 Finland

Paten or persistent foramen ovale

2.1

6.5

264

GD2SN

NOMESCO Finland

Lung ventilation SPECT

2.3

6.5

200

H05.2

ICD-10 Finland

Exophthalmic conditions

3.2

6.5

N07CA01

ATC

betahistine; oral

1.3

6.5

483

3770

SPAT1058

SPAT

PEF monitoring instruction

1.2

6.5

659

5337

A06AC51

ATC

ispaghula, combinations; oral

1.3

6.5

358

2682

S01GX05

ATC

lodoxamide; ophthalmic

1.7

6.5

105

611

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.2

6.5

1172

10031

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

1.5

6.5

170

1114

Z76

ICD-10 Finland

Persons encountering health services in other circumstances

1.5

6.5

213

1462

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.3

6.4

398

3029

T82

ICPC

Obesity

1.3

6.4

367

2761

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

1.7

6.4

112

664

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

1.4

6.4

276

1986

D07AD01

ATC

clobetasol; topical

1.2

6.4

1435

12485

CKC20

NOMESCO Finland

Cryopexy of undetached retina

3.0

6.4

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.8

6.4

795

9493

H65.3

ICD-10 Finland

Chronic mucoid otitis media

1.4

6.4

290

2105

G71.3

ICD-10 Finland

Mitochondrial myopathy, not elsewhere classified

5.6

6.4

WX003

NOMESCO Finland

Sedation or analgesia orally, rectally or intramuscularly without general anesthesia

1.9

6.4

374

R63.8

ICD-10 Finland

Other symptoms and signs concerning food and fluid intake

2.8

6.4

112

G72.9

ICD-10 Finland

Myopathy, unspecified

2.1

6.4

279

J05AH02

ATC

oseltamivir; oral

2.0

6.4

306

7410D

ICD-9 Finland

Spina bifida, With hydrocephalus[SPINA BIFIDA APERTA CUM HYDROCEPHALO REG LUMBALIS]

14.2

6.4

G91.1

ICD-10 Finland

Obstructive hydrocephalus

2.7

6.4

118

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

1.6

6.4

126

773

N03AX22

ATC

perampanel; oral

2.9

6.4

H35.0

ICD-10 Finland

Background retinopathy and retinal vascular changes

2.4

6.4

171

Z91.5

ICD-10 Finland

Personal history of self-harm

2.5

6.4

147

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.4

6.3

261

1865

A10AB01

ATC

insulin (human); parenteral

1.4

6.3

276

1991

F29

ICD-10 Finland

Unspecified nonorganic psychosis

1.3

6.3

339

2527

L29

ICPC

Musculoskeletal sympt/complt other

1.2

6.3

724

5938

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

1.5

6.3

159

1032

S06

ICPC

Rash localized

1.3

6.3

464

3616

NFL22

NOMESCO Finland

Myotomy or tenotomy of hip or thigh

3.7

6.3

L04AB01

ATC

etanercept; parenteral

1.6

6.3

144

915

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

1.8

6.3

498

P27.1

ICD-10 Finland

Bronchopulmonary dysplasia originating in the perinatal period

5.1

6.3

J30.3

ICD-10 Finland

Other allergic rhinitis

1.3

6.2

352

2645

H50.39

ICD-10 Finland

Intermittent heterotropia

17.9

6.2

LINSS, ,

NOMESCO Finland

+∞

6.2

3788X

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Other disorders of binocular eye movements

+∞

6.2

H50.5

ICD-10 Finland

Heterophoria

+∞

6.2

37309

ICD-8 Finland

Strabismus, Unspecified

+∞

6.2

37008

ICD-8 Finland

Refractive errors, Alia definita

+∞

6.2

3508

FHL

Transposition or anteposition

+∞

6.2

Z010, H521,

ICD-10 Finland

+∞

6.2

37304

ICD-8 Finland

Strabismus, paralyticus. Paresis nervorum III, IV, VI

+∞

6.2

R01AD11

ATC

triamcinolone; nasal

1.2

6.2

748

6164

R21

ICPC

Throat symptom/complaint

1.1

6.2

2747

24987

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.4

6.2

279

2023

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

2.1

6.2

262

CBJ50

NOMESCO Finland

Operation for ptosis of eyebrow

2.3

6.2

185

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

1.4

6.2

257

1838

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.1

6.2

3188

29240

F72.9

ICD-10 Finland

Severe mental retardation, without mention of impairment of behaviour

26.6

6.2

RK120, ,

NOMESCO Finland

2.9

6.2

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

1.6

6.2

131

817

H35.6

ICD-10 Finland

Retinal haemorrhage

2.3

6.2

198

2AB04, ,

NOMESCO Finland

2.8

6.2

103

R44

ICPC

Respiratory, Preventive immunization/medic

1.8

6.2

486

SPAT1377

SPAT

Polysomnography

1.4

6.2

250

1782

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

1.6

6.2

134

841

L88

ICPC

Rheumatoid/seropositive arthritis

1.4

6.2

309

2281

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

2.7

6.2

120

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.3

6.2

509

4025

WX204

NOMESCO Finland

Axillary plexus blockaced

1.4

6.2

239

1691

N80.9

ICD-10 Finland

Endometriosis, unspecified

1.5

6.2

192

1304

R4190

NOMESCO Finland

Nutritional therapy

1.3

6.2

390

2980

A02BA03

ATC

famotidine; systemic

1.4

6.1

215

1493

EB1WA, ,

NOMESCO Finland

2.1

6.1

257

G40

ICD-10 Finland

Epilepsy

1.9

6.1

394

DHB50

NOMESCO Finland

Turbinoplasty

1.4

6.1

216

1502

K06.19

ICD-10 Finland

Gingival hyperplasia UNS

2.4

6.1

174

M01AC06

ATC

meloxicam; systemic, rectal

1.1

6.1

3247

29831

UJF30

NOMESCO Finland

Ileoscopy through colon

1.2

6.1

836

6978

D11

ICPC

Diarrhoea

1.2

6.1

1249

10793

R5110, ,

SPAT

1.3

6.1

419

3236

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

1.7

6.1

539

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

2.1

6.1

264

EMB30

NOMESCO Finland

Adenotomy

1.3

6.1

413

3184

R51

NOMESCO Finland

Aids services

5.7

6.1

SPAT1043

SPAT

Audiometry

1.2

6.1

704

5780

K07

ICPC

Swollen ankles/oedema

1.4

6.1

256

1837

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

1.6

6.1

130

813

H33.2

ICD-10 Finland

Serous retinal detachment

3.2

6.1

G04CB01

ATC

finasteride; oral

1.3

6.1

484

3811

Z94.2

ICD-10 Finland

Lung transplant status

3.3

6.1

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.3

6.1

338

2536

G03DC03

ATC

lynestrenol; oral

1.5

6.1

202

1390

UDM02

NOMESCO Finland

Sinoscopy

1.5

6.1

164

1082

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.3

6.1

383

2926

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.4

6.1

275

1999

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

1.5

6.1

148

955

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.2

6.1

972

8234

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

1.4

6.0

211

1465

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

1.5

6.0

168

1115

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.6

6.0

146

940

K07.24

ICD-10 Finland

Open bite

1.6

6.0

139

885

H18.2

ICD-10 Finland

Other corneal oedema

3.7

6.0

K02.1

ICD-10 Finland

Caries of dentine

1.1

6.0

7172

68453

N05BA06

ATC

lorazepam; systemic, sublingual

1.3

6.0

333

2497

RT130, ,

NOMESCO Finland

3.0

6.0

199

Kela drug reimbursment

Rufinamide

10.0

6.0

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.2

6.0

1108

9498

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.3

6.0

493

3897

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5517

44007

1.42

80.48

2.7

2.3

75.38

2096.77

nmol/l

0.50

5060

40555

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5854

47946

1.38

69.57

7.9

6.6

1.22

mmol/l

0.97

4894

41089

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5334

43404

1.37

64.28

7.5

6.1

1.22

1.21

mmol/l

1.42

4868

39967

(40760892) CBC W Ordered Manual Differential panel - Blood

6211

51918

1.35

62.29

7.8

6.5

—

(3018418) pH of Serum or Plasma

3634

27881

1.41

61.98

4.4

3.9

7.40

0.61

717

5383

(3013707) Erythrocyte sedimentation rate by Westergren method

8972

79532

1.37

60.37

4.5

3.9

10.28

10.54

mm/h

1.16

8356

74301

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

9728

87393

1.39

60.05

4.6

3.9

14.55

pmol/l

0.07

8901

80449

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

8936

79238

1.36

59.49

7.6

7.1

76.95

77.69

u/l

0.74

8455

74934

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

11114

102329

1.46

58.67

5.3

4.6

2.17

2.05

mu/l

0.18

10355

95587

(3001604) Monocytes [#/volume] in Blood

6502

55091

1.34

57.89

7.2

6.0

0.56

e9/l

2.12

5788

48016

(3013115) Eosinophils [#/volume] in Blood

6710

57154

1.34

57.44

7.5

6.3

0.19

e9/l

0.11

6011

50538

(3006315) Basophils [#/volume] in Blood

6505

55191

1.34

57.04

7.2

6.0

0.04

e9/l

0.57

5780

48048

(3024561) Albumin [Mass/volume] in Serum or Plasma

5071

41690

1.34

54.19

5.3

4.9

36.38

36.26

g/l

0.86

4663

38937

(3019198) Lymphocytes [#/volume] in Blood

6679

57152

1.32

53.93

7.1

6.0

1.95

1.98

e9/l

1.57

6030

51004

(3037467) Urinalysis macro (dipstick) panel - Urine

8416

74488

1.33

53.27

4.9

4.0

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3571

27877

1.37

53.26

2.3

2.1

226.08

207.34

u/l

0.32

3347

26301

(3013650) Neutrophils [#/volume] in Blood by Automated count

7264

63247

1.31

50.11

10.0

9.0

3.91

3.99

e9/l

2.17

6479

55315

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1528

10337

1.53

48.77

2.3

2.2

363.39

373.93

nmol/l

1.27

1409

9546

(3015377) Calcium [Moles/volume] in Serum or Plasma

4023

32520

1.33

46.33

3.3

2.35

mmol/l

0.70

3559

29051

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4598

37887

1.32

46.21

1.9

1.8

98.78

97.27

pmol/l

1.34

2430

20143

(3023103) Potassium [Moles/volume] in Serum or Plasma

11741

110291

1.46

46.00

15.7

13.1

3.94

mmol/l

0.11

11443

107189

(3019550) Sodium [Moles/volume] in Serum or Plasma

11704

109969

1.45

44.90

15.6

13.0

139.62

139.63

mmol/l

0.23

11434

107131

(3013826) Glucose [Moles/volume] in Serum or Plasma

6843

59700

1.29

43.73

5.5

4.6

6.45

6.52

mmol/l

1.62

6348

55016

(3022096) Basophils/100 leukocytes in Blood

5854

50131

1.29

43.02

7.4

6.2

0.68

0.29

5526

47014

(3044889) 12 lead EKG panel

7878

70086

1.29

42.63

3.7

3.2

—

(3006504) Eosinophils/100 leukocytes in Blood

6026

51883

1.28

42.10

7.3

6.2

2.90

2.85

0.73

5704

48819

(3015736) pH of Urine

5152

43527

1.29

41.63

3.5

3.1

6.01

5.92

1.47

421

4167

(3019069) Monocytes/100 leukocytes in Blood

6049

52187

1.28

41.27

7.6

6.5

8.42

8.33

1.51

5729

49195

(3020564) Creatinine [Moles/volume] in Serum or Plasma

12283

116821

1.52

41.16

15.5

13.2

73.16

72.56

umol/l

1.24

12277

116782

(3035350) Ketones [Presence] in Urine by Test strip

6170

53498

1.27

39.89

4.0

3.3

0.00

estimate

0.09

1314

10730

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

161

511

3.16

39.74

1.1

1.38

8.40

nmol/l

1.34

105

(3002030) Lymphocytes/100 leukocytes in Blood

6240

54199

1.27

39.70

7.3

6.2

29.59

29.44

0.50

5930

51249

(3018010) Neutrophils/100 leukocytes in Blood

6154

53398

1.27

39.34

7.1

6.0

55.88

56.04

0.52

5834

50459

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3167

25260

1.32

38.62

2.3

2.78

2.81

mg/l

0.31

2681

21828

(3031040) Bacteria [#/volume] in Urine by Automated count

7906

70787

1.27

38.58

5.0

4.0

2655.50

1435.08

e6/l

0.66

105

862

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5975

51808

1.27

37.87

6.0

11.15

11.22

umol/l

0.12

5637

48961

(3009261) Glucose [Presence] in Urine by Test strip

6198

53980

1.27

37.83

4.0

3.4

0.01

0.00

estimate

0.61

1245

10127

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

10161

94023

1.31

37.52

5.3

4.9

38.48

38.63

mmol/mol

0.78

9484

88258

(3021601) Nitrite [Presence] in Urine by Test strip

6143

53543

1.26

36.88

5.3

4.5

0.00

estimate

0.26

1284

10389

(3001122) Ferritin [Mass/volume] in Serum or Plasma

6009

52306

1.26

36.24

3.2

2.9

97.92

100.89

ug/l

0.39

5597

49205

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3494

28573

1.29

34.79

1.4

1.3

1.95

1.87

u/ml

0.10

935

7698

(3021960) Folate [Moles/volume] in Serum or Plasma

2636

20775

1.33

34.34

1.6

1.5

20.48

20.45

nmol/l

0.03

2270

18108

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1724

12719

1.40

34.26

8.1

6.3

1.08

1.07

mmol/l

0.57

1595

11937

(3019309) Folate [Moles/volume] in Red Blood Cells

2030

15386

1.37

34.25

1.8

1.7

1207.70

1166.30

nmol/l

1.25

1507

11880

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4087

34208

1.27

33.56

3.4

3.1

118.37

64.57

ng/l

0.41

2351

19790

(3037522) Nuclear Ab [Titer] in Serum

2068

15800

1.36

33.04

1.4

522.38

535.48

titre

0.10

403

3161

(3005719) IgG [Mass/volume] in Serum or Plasma

1211

8448

1.47

32.62

2.9

2.7

9.98

10.42

g/l

4.03

1100

7783

(40761511) CBC panel - Blood by Automated count

12274

117475

1.44

31.95

13.4

11.0

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1905

14490

1.36

31.16

2.6

2.4

29.43

29.75

1.45

1853

14068

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3806

31824

1.27

30.94

2.8

2.5

56.89

61.45

u/l

0.93

3480

29518

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

12281

117650

1.43

30.85

10.8

9.3

26.22

26.55

u/l

0.67

11872

114067

(3007164) IgA [Mass/volume] in Serum or Plasma

3045

24804

1.29

30.53

1.5

1.4

2.14

2.23

g/l

2.21

1873

15390

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

11784

112151

1.36

30.41

14.4

11.9

20.61

21.79

mg/l

3.52

9280

86595

(3029937) Albumin [Presence] in Urine by Test strip

3417

28367

1.27

29.14

4.4

3.7

0.00

estimate

4.09

1236

10081

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2462

19620

1.31

28.97

1.7

1.6

32061889.29

32454365.59

pmol/l

0.01

2018

16716

(3000850) Epithelial cells [#/volume] in Urine

2607

20943

1.30

28.86

3.1

2.5

6.70

6.47

e6/l

0.31

2349

18690

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

219

967

2.28

28.23

1.1

217.29

241.82

mg/l

1.38

184

858

(3021589) Normoblasts [#/volume] in Blood

5597

49204

1.23

28.13

10.8

8.9

0.00

e9/l

1.19

4635

40159

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

223

994

2.26

28.10

1.2

1.1

32.61

39.77

mg/l

2.81

173

835

(3044290) Cell count panel - Cerebral spinal fluid

418

2333

1.81

28.04

1.7

1.6

—

(1616796) Gas panel - Central venous blood

383

2082

1.86

27.98

4.4

3.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

704

4519

1.58

27.92

1.3

1.56

1.00

u/ml

0.38

374

(3022217) INR in Platelet poor plasma by Coagulation assay

4812

41665

1.23

27.91

12.3

11.5

1.19

1.18

inr

0.31

1638

12784

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

479

2786

1.74

27.90

1.6

1.5

427.25

490.61

mg/l

3.66

451

2661

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

188

790

2.39

27.17

1.6

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

10821

102121

1.28

27.08

4.2

3.9

5.74

5.77

mmol/l

1.70

9927

94788

(3026782) Osmolality of Urine

2455

19712

1.29

27.06

3.3

2.7

535.16

546.23

mosm/kgh2o

1.45

2107

16895

(3018095) Leukocytes [#/volume] in Urine

4282

36713

1.24

27.00

4.2

3.5

62.74

83.36

e6/l

1.53

3005

24966

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1281

9340

1.40

26.90

3.6

3.0

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

433

2478

1.76

26.70

1.7

1.6

20.78

23.91

e6/l

0.22

338

1881

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

432

2481

1.76

26.32

1.7

10438.47

1136.99

e6/l

0.56

354

1984

(3013005) Retinol [Moles/volume] in Serum or Plasma

161

641

2.52

26.17

2.5

2.4

1.95

1.83

umol/l

0.85

152

611

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

430

2475

1.75

26.00

1.5

3.56

3.65

mmol/l

1.32

397

2337

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1972

15451

1.32

25.96

4.8

3.9

0.82

mmol/l

0.67

1814

14579

(3009542) Hematocrit [Volume Fraction] of Blood

12994

126355

1.63

25.80

21.4

17.6

40.32

40.59

1.77

12172

119793

(3022948) Iron [Moles/volume] in Serum or Plasma

1958

15339

1.32

25.79

2.8

2.4

13.74

13.84

umol/l

0.26

1803

14420

(3002582) Erythrocytes [#/volume] in Urine

3603

30435

1.24

25.79

3.7

3.1

76.60

77.04

e6/l

0.01

2814

22970

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2883

23757

1.27

25.60

2.0

1.9

0.97

1.08

mg/l

1.27

2109

17678

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1062

7562

1.43

25.45

4.7

3.7

1.23

mmol/l

0.30

883

6645

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

521

3187

1.65

25.17

10.1

6.4

1.39

1.34

mg/l

0.68

488

3010

(3035941) MCH [Entitic mass]

13008

126576

1.63

25.10

21.1

17.4

30.10

0.06

12858

125111

(3024731) MCV [Entitic volume]

13008

126584

1.62

24.99

21.1

17.5

90.15

90.18

0.33

12858

125115

(3007853) Bacteria identified in Skin by Aerobe culture

1630

12490

1.34

24.99

1.9

1.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4760

41513

1.22

24.90

4.1

3.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

976

6874

1.45

24.80

4.9

4.1

82.77

83.57

ng/l

0.08

844

6086

(3007461) Platelets [#/volume] in Blood

12997

126470

1.61

24.74

21.2

17.5

257.76

258.52

e9/l

0.69

12735

123471

(3010813) Leukocytes [#/volume] in Blood

13009

126617

1.62

24.71

21.2

17.5

6.61

6.70

e9/l

4.82

12722

123316

(3026361) Erythrocytes [#/volume] in Blood

13008

126605

1.62

24.71

21.2

17.5

4.53

e12/l

0.71

12723

123350

(3000963) Hemoglobin [Mass/volume] in Blood

13011

126657

1.62

24.50

21.4

17.6

135.54

135.81

g/l

1.41

12863

125196

(3030467) Casts [#/volume] in Urine by Automated count

3309

27869

1.24

24.00

3.6

3.0

0.33

0.37

e6/l

0.46

2557

20796

(3027315) Oxygen [Partial pressure] in Blood

378

2157

1.77

23.58

4.7

3.9

8.76

8.83

kpa

0.34

369

2118

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2064

16468

1.29

23.54

2.8

2.9

2.44

mmol/l

0.26

1787

14382

(3012501) Base excess in Blood by calculation

375

2139

1.77

23.43

4.8

3.9

2.23

2.34

mmol/l

0.32

262

1410

(3013290) Carbon dioxide [Partial pressure] in Blood

375

2140

1.77

23.39

4.8

3.9

5.05

5.01

kpa

0.51

366

2102

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4175

36117

1.22

23.27

3.6

3.3

30.24

33.16

u/l

2.15

3963

34360

(3028626) Oxygen [Partial pressure] in Capillary blood

515

3211

1.62

23.07

8.5

5.4

9.08

8.99

kpa

0.50

504

3127

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1040

7505

1.41

23.07

3.3

4.55

4.57

pmol/l

0.24

929

6732

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1783

14015

1.31

22.69

2.8

2.4

2.42

2.40

g/l

0.61

1630

13060

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

200

932

2.15

22.68

1.1

—

(40761536) Microorganisms panel - Urine sediment

1262

9444

1.37

22.47

4.8

3.5

—

(40768797) Stomach Pathology biopsy report

1737

13626

1.31

22.41

1.3

1.2

—

(36304419) Bacteria [Presence] in Urine

3259

27589

1.23

22.23

3.5

2.9

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

245

1241

1.98

22.22

3.1

2.7

22.37

21.26

nmol/l

0.60

233

1188

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

953

6824

1.42

22.07

11.1

8.6

24.83

24.70

mmol/l

0.60

945

6784

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

660

4404

1.52

21.97

2.1

2.0

39.66

39.79

u/l

0.06

598

3992

(3010421) pH of Blood

414

2477

1.69

21.80

4.8

3.8

7.42

0.07

391

2264

(3005322) IgE [Units/volume] in Serum or Plasma

1102

8112

1.38

21.71

1.4

1.3

205.28

236.96

u/ml

0.57

1012

7518

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1039

7600

1.39

21.25

2.2

2.1

11.75

11.78

nmol/l

0.03

921

6869

(3048689) Calprotectin [Mass/mass] in Stool

1977

15876

1.28

21.24

2.4

2.5

110.79

123.03

ug/g

0.88

1572

12576

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

148

626

2.37

21.19

1.1

1.03

1.05

u/l

0.19

292

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1061

7799

1.39

21.07

2.4

2.3

25.49

22.23

au/ml

0.29

711

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2643

22005

1.24

20.83

3.1

2.9

935.22

1115.77

ng/l

1.93

2150

18486

(3002385) Erythrocyte distribution width [Ratio]

10469

99188

1.23

20.82

17.4

14.3

14.27

14.74

4.20

10306

97472

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

11188

106776

1.25

20.71

4.7

4.2

2.80

2.83

mmol/l

3.79

10398

100282

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

11072

105548

1.25

20.69

4.3

3.9

4.69

4.73

mmol/l

4.29

10304

99679

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1647

12965

1.30

20.60

2.9

2.5

23.19

23.45

0.31

1382

11252

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

8286

76831

1.19

20.59

3.4

3.0

40.19

41.92

u/l

1.29

7766

72773

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3121

26483

1.23

20.53

1.7

1.6

1.34

1.38

mmol/l

1.77

2624

22765

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1843

14737

1.28

20.42

1.8

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2358

19441

1.25

20.21

1.3

27.17

31.20

iu/ml

0.68

722

6118

(3011397) Hemoglobin [Presence] in Urine by Test strip

2925

24724

1.23

19.87

3.7

3.4

—

(40767503) Oxygen content in Capillary blood by calculation

338

1965

1.73

19.81

2.9

2.4

17.01

16.73

0.63

193

984

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

976

7170

1.38

19.42

1.3

45.60

51.38

au/ml

0.25

365

(3023368) Bacteria identified in Blood by Culture

2869

24275

1.22

19.20

4.3

4.1

—

(3026008) Bacteria identified in Urine by Culture

3503

30233

1.21

19.17

3.3

2.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1296

9973

1.33

19.04

1.8

1.7

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

10625

101071

1.22

18.95

3.8

3.5

1.26

1.27

mmol/l

1.45

9842

94571

(3021901) Oxygen saturation in Capillary blood

286

1612

1.78

18.69

4.0

2.9

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

10976

104801

1.23

18.63

4.2

3.9

1.48

1.47

mmol/l

0.77

10207

98626

(3028026) IgM [Mass/volume] in Serum or Plasma

901

6577

1.39

18.62

2.0

1.8

1.34

1.29

g/l

0.28

827

6078

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1283

9894

1.32

18.55

1.7

—

(3033658) Prothrombin time (PT) actual/Normal

3073

26280

1.21

18.35

4.5

4.0

93.30

92.75

0.62

2979

25606

(3020630) Protein [Mass/volume] in Serum or Plasma

915

6741

1.38

17.87

2.5

66.75

66.78

g/l

0.05

841

6214

(3041096) Erythrocytes [Presence] in Urine by Automated

3481

30202

1.20

17.74

3.7

2.9

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

10588

100870

1.21

17.62

12.4

10.8

88.16

88.20

ml/min/173m2

0.06

8651

82073

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

524

3498

1.51

17.44

1.9

1.8

0.23

g/l

0.18

491

3332

(3009508) Creatinine [Moles/volume] in Urine

3451

29973

1.20

17.30

3.6

3.2

7.72

7.91

mmol/l

1.47

2989

25998

(3009466) Valproate [Moles/volume] in Serum or Plasma

271

1542

1.77

17.19

5.7

5.3

414.64

369.69

umol/l

4.45

241

1360

(3015235) Bicarbonate [Moles/volume] in Capillary blood

373

2316

1.62

17.08

5.1

3.4

24.16

24.49

mmol/l

0.80

366

2268

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

5.62

16.67

7.8

7.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1259

9823

1.30

16.66

3.5

2.9

1.66

1.74

1.90

1108

8823

(3000494) Fungus identified in Specimen by Culture

1528

12231

1.28

16.57

1.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1162

8987

1.31

16.39

6.9

4.8

5.86

5.84

kpa

0.35

1131

8722

(3018133) Calcium [Moles/volume] in Urine

286

2.80

16.28

2.4

3.0

2.79

2.62

mmol/l

0.28

262

(4200892) Spirometry reversibility

943

7100

1.35

16.01

1.4

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

223

1226

1.83

15.90

1.1

—

11.28

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2197

18398

1.23

15.90

1.3

7.43

11.11

u/ml

2.21

844

7502

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

723

5223

1.40

15.89

1.1

49.78

7.28

u/ml

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

206

1107

1.87

15.80

1.1

1.0

—

(3002032) Base excess in Venous blood by calculation

1154

8963

1.31

15.77

6.9

4.8

1.77

1.79

mmol/l

0.07

972

7520

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

527

3598

1.48

15.74

1.9

1.8

1.17

1.18

g/l

0.14

498

3436

(3012544) pH of Venous blood

1187

9264

1.30

15.65

6.8

4.8

7.37

0.02

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1181

9214

1.30

15.61

1.2

134.95

147.32

iu/ml

0.54

436

3519

(3024354) Oxygen [Partial pressure] in Venous blood

988

7521

1.33

15.57

6.6

4.4

4.77

4.78

kpa

0.06

959

7284

(3023520) Reticulocytes [#/volume] in Blood

939

7120

1.34

15.20

3.2

2.7

69.31

70.33

e9/l

0.33

696

5225

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2100

17594

1.22

15.05

3.7

3.4

405.70

492.26

ng/l

0.32

1431

11940

(3022145) Colonoscopy Study observation

1418

11379

1.27

15.00

1.3

1.4

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

186

986

1.89

14.91

3.0

2.3

12.92

13.37

0.26

180

964

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

4.44

14.81

6.4

4.7

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1022

7880

1.32

14.71

4.2

4.0

0.52

0.66

1.67

305

2421

(3006245) CD3-CD19+ cells/100 cells in Blood

131

620

2.12

14.46

3.5

2.7

12.40

0.00

123

593

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

160

3.31

14.46

1.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

177

933

1.90

14.45

3.1

2.4

—

(3042936) Bacteria identified in Isolate by Culture

1686

13858

1.24

14.45

2.1

2.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

300

1847

1.63

14.28

4.6

3.1

—

(3019150) Specific gravity of Urine by Refractometry

2708

23355

1.19

14.24

4.0

3.6

1.02

kg/l

0.65

418

3491

(1175426) CD3 cells/100 lymphocytes in Blood

186

1003

1.86

14.17

3.0

2.3

73.30

72.53

0.28

180

969

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

4.28

14.16

6.8

4.8

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

878

6675

1.33

13.96

6.9

4.6

5.10

5.11

kpa

0.09

841

6383

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

846

6399

1.34

13.92

7.0

4.6

1.49

1.44

mmol/l

0.16

618

4663

(3009343) pH of Capillary blood

868

6601

1.33

13.77

7.0

4.6

7.42

7.41

0.13

142

722

(3009214) Lutropin [Units/volume] in Serum or Plasma

627

4532

1.40

13.75

1.6

1.5

9.79

9.43

u/l

0.26

490

3634

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

891

6812

1.32

13.62

1.7

—

(3000060) B lymphocytes [#/volume] in Blood

110

498

2.21

13.61

3.4

2.7

265.08

270.84

e6/l

0.04

287

(3003327) Ova and parasites identified in Stool by Light microscopy

606

4364

1.40

13.59

1.8

1.7

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1062

8319

1.29

13.58

11.5

8.1

8.03

8.48

mmol/l

1.67

1028

7982

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1390

11263

1.26

13.49

5.7

5.9

—

(3011412) CD3 cells [#/volume] in Blood

211

1211

1.75

13.11

3.2

2.6

1.39

1.27

e9/l

0.93

181

1038

(3000570) Elastase.pancreatic [Mass/mass] in Stool

420

2847

1.48

13.06

1.4

287.29

284.44

ug/g

0.10

227

1578

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2587

22380

1.19

12.98

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

438

3000

1.47

12.93

2.3

2.4

452.71

468.76

ug/l

0.04

399

2779

(3017181) Myelocytes/100 leukocytes in Blood

1084

8571

1.28

12.88

4.6

4.3

0.80

0.90

0.58

342

2744

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

876

6744

1.31

12.74

3.0

2.9

139.56

161.57

ng/l

1.20

797

6038

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

122

591

2.07

12.73

3.4

2.5

25.76

27.51

0.92

116

569

(3026493) Urate [Moles/volume] in Serum or Plasma

2912

25510

1.17

12.52

2.8

2.5

3739.00

3443.16

umol/l

0.17

2563

22822

(3025159) Blasts/100 leukocytes in Blood

997

7834

1.29

12.44

4.8

4.3

0.72

0.25

0.62

258

2020

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

370

2478

1.50

12.24

1.3

47.50

44.57

u/ml

0.12

233

(3012516) Albumin [Mass/volume] in Urine

2872

25176

1.17

12.20

3.4

3.3

616.26

437.08

mg/l

0.86

1791

16226

(40758558) Short blood count panel - Blood

3119

27530

1.17

12.14

7.6

7.0

—

(3021440) Promyelocytes/100 leukocytes in Blood

1033

8182

1.28

12.10

4.7

4.3

0.07

0.12

2.58

292

2362

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

408

2795

1.47

12.06

2.3

2.1

10.12

10.74

mg/l

0.93

374

2624

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1984

16886

1.20

11.86

3.0

2.6

1.03

1.29

e6/l

0.71

1152

9312

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

717

5427

1.33

11.77

7.4

5.4

23.98

24.01

mmol/l

0.10

705

5350

(3013139) Helicobacter pylori Ag [Presence] in Stool

927

7270

1.29

11.74

1.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

582

4277

1.37

11.59

1.6

25.03

9.20

u/ml

0.84

130

(3020961) Endomysium IgA Ab [Titer] in Serum

842

6545

1.30

11.42

1.1

1.2

220.87

237.30

titre

0.07

187

(3000991) Gas panel - Venous blood

1048

8379

1.27

11.36

10.9

8.9

—

(40768804) Tissue Pathology biopsy report

4708

42973

1.14

11.27

2.0

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1003

7996

1.27

11.14

8.8

7.8

1.33

mmol/l

0.01

974

7810

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

446

3157

1.42

11.10

1.3

40.52

39.43

u/ml

0.03

202

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

511

3707

1.39

11.03

1.6

59.71

2.99

iu/ml

0.89

109

765

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

341

2305

1.49

10.83

8.0

6.1

789.42

1529.71

iu/ml

0.38

301

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

176

1016

1.73

10.80

1.7

1.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

700

5349

1.32

10.77

2.1

2.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

489

3538

1.39

10.73

3.7

3.3

3.39

3.48

g/l

0.73

468

3364

(3020682) Albumin/Creatinine [Ratio] in Urine

2972

26368

1.16

10.59

4.0

3.9

9.83

10.51

mg/mmol

0.23

1849

16979

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

524

3846

1.37

10.54

3.9

3.1

93.40

93.59

0.07

497

3709

(3036489) Thrombin time

579

4317

1.35

10.54

2.7

2.6

21.46

21.39

0.14

481

3719

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

164

936

1.75

10.49

3.4

2.8

510.40

530.35

e6/l

0.23

131

753

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

404

2847

1.43

10.33

1.4

1.3

5.15

8.46

u/ml

0.58

273

(3010375) cycloSPORINE [Mass/volume] in Blood

110

556

1.98

10.31

29.9

27.0

122.19

122.60

ug/l

0.02

464

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

470

3402

1.39

10.31

1.8

1.6

228.26

304.72

titre

0.28

144

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

161

920

1.75

10.27

3.5

2.8

0.23

0.21

e9/l

0.22

131

754

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

408

2890

1.42

10.15

1.3

9.26

9.96

u/ml

0.08

440

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

341

2338

1.46

10.11

1.8

1.7

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

466

3380

1.39

10.10

6.3

4.9

0.92

0.91

0.11

442

3142

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

477

3474

1.38

10.09

2.0

1.8

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

188

1127

1.67

10.08

1.8

1.7

—

(3026250) Tacrolimus [Mass/volume] in Blood

108

548

1.97

10.02

42.0

37.6

6.99

7.32

ug/l

0.93

514

(3006184) Hemoglobin [Mass/volume] in Capillary blood

313

2117

1.48

9.95

2.5

2.2

131.33

131.15

g/l

0.04

250

1545

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

284

1883

1.51

9.94

1.7

1.6

—

(36660697) Celiac disease serology panel - Serum

1258

10421

1.22

9.88

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

240

1541

1.56

9.74

1.6

—

(3023410) Appearance of Cerebral spinal fluid

199

1222

1.63

9.73

2.0

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

200

1230

1.63

9.72

1.3

0.39

0.38

g/l

0.09

153

860

(3028192) IgG subclass 2 [Mass/volume] in Serum

200

1230

1.63

9.72

1.3

3.09

2.86

g/l

1.12

149

866

(3027135) IgG subclass 1 [Mass/volume] in Serum

200

1230

1.63

9.72

1.3

6.36

6.61

g/l

0.65

151

865

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

468

3420

1.38

9.71

6.2

4.9

1.73

1.71

0.17

441

3173

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

332

2284

1.46

9.69

1.8

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

217

1363

1.60

9.68

1.8

1.6

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

952

7672

1.25

9.65

2.4

2.3

6374.21

6067.84

u/l

0.08

308

3030

(4062490) Immunoglobulin typing, IgG

199

1227

1.62

9.58

1.4

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1328

11094

1.21

9.58

8.0

7.4

104.83

104.57

mmol/l

1.20

1328

11086

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

269

1779

1.52

9.55

6.8

3.5

1392.24

875.15

u/ml

0.25

100

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1230

10205

1.22

9.51

4.7

4.4

238.65

240.33

u/l

0.13

1174

9691

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

405

2909

1.40

9.33

2.0

1.9

4.18

6.96

iu/l

0.50

137

1139

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

476

3517

1.36

9.23

3.0

3.1

169.59

178.31

1.52

448

3343

(3023323) Follitropin [Units/volume] in Serum or Plasma

933

7543

1.25

9.20

1.5

1.4

24.14

25.97

iu/l

0.94

769

6429

(3016018) Differential panel - Cerebral spinal fluid

205

1289

1.59

9.13

1.8

1.7

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

351

2.16

9.11

1.2

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

221

2.48

9.07

9.4

6.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

245

1610

1.53

8.99

1.6

1.5

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

148

2.83

8.95

4.7

3.8

—

(1002224) Polysomnography panel

640

4961

1.30

8.91

1.1

—

(3013512) EKG study

2901

25967

1.14

8.90

3.7

3.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2527

22405

1.15

8.89

4.6

4.3

2.18

2.83

ug/l

1.30

2265

20341

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1170

9731

1.22

8.82

8.7

7.5

5.08

kpa

0.01

1124

9283

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

252

1674

1.51

8.80

1.8

—

(3016244) Insulin [Units/volume] in Serum or Plasma

177

1084

1.63

8.80

3.2

3.4

26.32

26.10

mu/l

0.02

167

1025

(3002173) Hemoglobin [Mass/volume] in Arterial blood

982

8024

1.24

8.80

9.3

8.3

123.26

122.25

g/l

0.83

961

7785

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

452

3342

1.36

8.75

1.7

39.45

41.30

nmol/l

0.77

443

3266

(3027801) Oxygen [Partial pressure] in Arterial blood

1168

9727

1.21

8.69

8.7

7.5

12.92

12.97

kpa

0.09

1123

9272

(3013336) Amino acids [Identifier] in Serum or Plasma

3.33

8.67

2.0

2.9

—

(3023420) DNA double strand Ab [Units/volume] in Serum

199

1262

1.58

8.58

1.7

1.6

24.25

31.85

iu/ml

0.67

(3049233) Organic acids panel - Urine

4.36

8.54

1.0

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

136

2.86

8.49

6.9

6.0

2.65

2.22

mg/l

0.60

115

(3025941) Bacteria identified in Stool by Culture

832

6721

1.25

8.28

1.3

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

144

850

1.69

8.27

1.4

1.2

1.98

1.93

mmol/l

0.23

133

799

(3003396) Base excess in Arterial blood by calculation

1163

9729

1.21

8.26

8.7

7.5

0.94

0.92

mmol/l

0.07

931

7673

(3016502) Oxygen saturation in Arterial blood

1042

8626

1.22

8.24

9.2

8.0

95.54

95.88

0.65

1011

8272

(3004119) Hemoglobin [Mass/volume] in Venous blood

661

5201

1.28

8.22

5.8

4.0

129.75

130.51

g/l

0.40

643

5078

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

233

1548

1.51

8.17

1.6

1.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

519

1.89

8.11

2.7

2.5

56.20

51.35

umol/l

0.70

464

(3021387) Prolactin [Units/volume] in Serum or Plasma

737

5891

1.26

8.05

1.7

1.6

327.50

311.63

mu/l

0.50

654

5313

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

142

846

1.68

7.90

2.7

2.9

98.39

96.80

0.24

130

786

(3010838) Calcium [Moles/time] in 24 hour Urine

255

1740

1.47

7.85

2.0

1.9

5.69

5.17

mmol/24h

0.65

234

1553

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

168

1048

1.60

7.81

2.1

33.02

32.60

0.64

168

1040

(42529406) Shigella sp [Presence] in Stool by Culture

437

3275

1.34

7.79

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

609

4783

1.28

7.70

11.5

10.1

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

133

2.78

7.65

1.8

1.7

2.07

2.67

mg/l

0.26

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

133

2.78

7.65

1.8

1.7

0.92

1.30

mg/l

0.40

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

133

2.78

7.65

1.8

1.7

0.76

1.27

mg/l

0.91

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

133

2.78

7.65

1.8

1.7

2.33

3.67

mg/l

0.96

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

133

2.78

7.65

1.8

1.7

1.60

2.68

mg/l

0.86

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

133

2.78

7.65

1.8

1.7

0.94

2.11

mg/l

1.47

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

133

2.78

7.65

1.8

1.7

1.66

1.89

mg/l

0.18

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

133

2.78

7.65

1.8

1.7

3.06

4.22

mg/l

0.64

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

312

2222

1.41

7.64

1.7

1.8

187.10

189.01

pmol/l

0.11

305

2119

(3008152) Bicarbonate [Moles/volume] in Arterial blood

658

5226

1.27

7.60

7.7

6.7

24.67

24.47

mmol/l

0.70

632

4945

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

3162

28708

1.13

7.59

1.7

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

290

2041

1.42

7.59

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

290

2042

1.42

7.57

1.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

146

2.67

7.48

1.3

1.2

—

(3047181) Lactate [Moles/volume] in Blood

393

2919

1.35

7.45

7.2

5.3

1.22

1.28

mmol/l

0.77

357

2557

(3017143) Hepatitis C virus Ab [Presence] in Serum

1856

16286

1.16

7.45

1.7

1.6

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

124

2.82

7.44

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

429

3231

1.33

7.41

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

110

622

1.77

7.41

1.2

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

102

565

1.80

7.37

1.4

1.2

76.50

71.27

0.28

(3027273) Bicarbonate [Moles/volume] in Venous blood

510

3940

1.30

7.35

5.3

3.6

25.22

25.20

mmol/l

0.04

497

3807

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1396

11999

1.18

7.31

3.4

3.0

6.46

7.56

umol/l

1.70

1172

10310

(3014765) Yersinia sp identified in Stool by Organism specific culture

431

3259

1.33

7.25

1.2

—

(3019060) Gas panel - Arterial blood

672

5388

1.25

7.18

5.6

4.6

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

138

2.68

7.16

1.8

1.7

0.75

2.19

mg/l

2.72

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

139

849

1.64

7.08

1.2

1.1

—

(3000012) Reticulocyte production index

171

1105

1.55

6.89

2.2

2.1

—

(3052851) Hemolysis interference index of Serum or Plasma

400

3021

1.33

6.81

3.0

2.9

—

(3023419) Bacteria identified in Sputum by Culture

181

1189

1.52

6.77

2.6

2.8

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

255

1793

1.42

6.76

1.4

1.2

133.33

125.33

titre

—

(40768443) Skin Pathology biopsy report

555

4384

1.27

6.75

1.2

—

(3022313) Gas panel - Capillary blood

620

4965

1.26

6.72

7.6

4.9

—

(3039000) Anion gap in Blood

274

1958

1.40

6.64

8.4

6.4

10.84

11.26

mmol/l

1.47

257

1740

(3018572) Chloride [Moles/volume] in Blood

274

1959

1.40

6.62

8.4

6.4

104.86

105.26

mmol/l

0.64

257

1741

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5420

50938

1.10

6.60

2.6

2.5

—

(3016038) Potassium [Moles/volume] in Urine

103

593

1.74

6.57

2.6

1.6

33.50

35.00

mmol/l

0.23

530

(3000492) Spirometry study

1314

11336

1.17

6.57

1.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

315

2308

1.37

6.57

1.3

4.47

3.46

u/ml

0.13

163

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

336

2487

1.35

6.57

1.4

1.5

0.36

0.40

nmol/l

0.49

268

1980

(3020717) Zinc [Moles/volume] in Serum or Plasma

115

683

1.68

6.56

1.9

1.6

20.87

24.05

umol/l

0.62

109

655

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

158

1015

1.56

6.56

1.3

5.52

5.46

umol/l

0.07

149

933

(3030981) Hyaline casts [#/volume] in Urine by Automated count

610

4900

1.25

6.45

3.0

2.5

0.22

0.27

e6/l

0.50

590

4738

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

624

5026

1.25

6.44

2.0

1.9

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

269

1929

1.40

6.40

1.9

3.86

7.78

titre

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

221

2.21

6.35

1.6

1.5

—

(1761868) Lipid panel - Serum or Plasma

4454

41522

1.10

6.34

2.7

2.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1798

15917

1.14

6.33

3.2

2.8

3.63

3.15

e6/l

0.88

971

8382

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

267

2.09

6.32

1.3

115.76

113.23

nmol/l

0.06

197

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

476

1.80

6.29

1.1

1.2

112.91

106.99

0.59

428

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2000

17840

1.14

6.28

4.1

3.8

21.63

21.62

0.01

843

7766

(3004451) EKG impression Narrative

370

1.92

6.27

1.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

470

3673

1.28

6.26

1.1

10.87

6.23

u/ml

0.53

523

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

223

2.19

6.22

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

373

2830

1.32

6.19

2.0

2.1

10.00

10.19

g/l

0.35

340

2542

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

344

1.94

6.18

2.1

1.7

0.15

0.19

nmol/l

0.61

252

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

135

852

1.58

6.08

1.3

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

266

1922

1.39

6.08

1.3

1.6

0.56

0.74

g/l

4.10

197

1476

(3051651) Icteric interference index of Serum or Plasma

110

660

1.67

6.07

3.7

3.8

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

364

2762

1.32

6.05

1.9

1.7

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

275

2003

1.38

5.99

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

511

4058

1.26

5.99

1.5

1.3

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

550

1.73

5.99

1.5

1.7

2.26

8.24

nmol/l

0.73

449

(3020393) Adenovirus Ag [Presence] in Stool

221

2.17

5.94

2.2

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

185

1257

1.47

5.94

1.6

1.4

—

(40761535) Cells panel - Urine sediment

900

7586

1.19

5.94

3.8

3.3

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

129

811

1.59

5.92

11.8

13.1

829.67

816.33

nmol/l

0.12

122

781

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

132

835

1.58

5.90

18.0

18.9

1478.82

2539.49

nmol/l

0.46

125

809

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

135

859

1.57

5.89

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

339

2559

1.33

5.86

1.9

1.5

127.33

112.27

u/ml

0.55

485

(3019420) Tryptase [Mass/volume] in Serum or Plasma

115

705

1.63

5.86

1.8

1.5

9.87

6.89

ug/l

0.46

106

633

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

179

1213

1.48

5.83

1.8

1.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

448

3513

1.28

5.83

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

209

1460

1.43

5.81

1.3

84.35

51.74

u/ml

0.88

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

179

1214

1.47

5.81

1.8

1.6

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

454

1.78

5.73

1.1

93.34

92.58

0.06

208

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

236

1691

1.40

5.70

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

236

1692

1.40

5.68

1.8

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

110

674

1.63

5.63

1.6

1.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

464

1.76

5.62

1.1

93.18

92.75

0.06

206

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

351

2683

1.31

5.57

2.8

2.6

—

(3008295) Osmolality of Serum or Plasma

154

1024

1.50

5.53

1.8

1.6

284.09

281.88

mosm/kgh2o

0.70

117

800

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

189

1310

1.44

5.51

1.3

1.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1085

9353

1.17

5.50

2.6

2.5

0.22

g/l

0.62

1019

8742

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

591

4821

1.23

5.48

1.5

1.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

357

2742

1.30

5.48

1.8

1.5

33.25

21.19

u/ml

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

197

2.18

5.42

1.9

2.4

—

(4094501) Cardiovascular stress test using bicycle ergometer

331

2521

1.32

5.41

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

591

4830

1.23

5.39

1.6

3.97

3.93

mg/l

0.03

440

3434

(3012565) Volume of 24 hour Urine

485

1.73

5.39

2.2

2.1

1860.87

2056.35

1.07

438

(3033923) Metanephrine [Moles/time] in 24 hour Urine

185

2.21

5.37

1.1

0.62

0.73

umol/24h

1.18

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

166

1129

1.47

5.35

1.5

1.4

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

302

2275

1.33

5.33

1.3

1.2

23.82

18.53

u/ml

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

600

1.65

5.32

1.2

1.1

—

(3024928) Oxygen saturation in Venous blood

267

1977

1.35

5.30

6.4

4.8

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

131

2.44

5.22

1.2

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

854

7255

1.18

5.18

1.1

—

(3037121) Protein [Mass/volume] in Urine

442

3519

1.26

5.13

4.5

3.6

0.32

0.36

g/l

0.34

221

1657

(3042631) Mycobacterium sp identified in Specimen

154

1042

1.48

5.12

2.4

2.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

356

2761

1.29

5.11

1.9

1.5

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1122

9756

1.16

5.09

2.5

34.17

44.49

u/l

1.12

955

8372

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

807

6837

1.19

5.06

2.1

2.2

7.92

7.50

ug/l

0.17

704

5993

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

191

1350

1.42

5.04

1.5

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

470

3777

1.25

5.03

1.4

1.3

—

(3011985) Renin [Units/volume] in Plasma

201

1434

1.40

5.03

1.7

1.6

62.65

69.34

mu/l

0.26

174

1299

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

3.54

5.00

1.4

1.2

1.00

1.14

u/field

—

(3051611) Lipemic interference index of Serum or Plasma

150

1015

1.48

4.99

3.6

3.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

916

7853

1.17

4.99

2.4

2.5

70.70

71.72

ml/min/173m2

0.32

400

2969

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

286

1.92

4.97

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

100

620

1.61

4.94

2.6

2.8

44.71

42.05

0.79

328

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

136

905

1.50

4.92

1.4

1.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

161

1110

1.45

4.88

1.5

1.6

52.21

54.07

0.22

695

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

386

3044

1.27

4.87

2.0

2.1

3.58

3.65

g/l

0.54

356

2776

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

386

3045

1.27

4.86

2.0

2.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

289

1.90

4.83

1.1

—

(40768446) Kidney Pathology biopsy report

464

1.70

4.81

2.2

1.7

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

353

2758

1.28

4.81

1.5

1.4

6.69

10.86

iu/ml

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

290

1.89

4.79

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

187

1332

1.40

4.75

1.4

352.36

456.31

pmol/l

0.62

155

1167

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

103

651

1.58

4.72

1.9

1.8

129.20

133.32

0.28

612

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

367

2890

1.27

4.70

2.0

2.1

2.82

2.92

g/l

1.02

337

2622

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

605

1.60

4.70

1.8

1.6

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

385

3050

1.26

4.69

2.0

2.1

7.23

7.36

g/l

0.82

355

2780

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

258

1940

1.33

4.67

1.2

1.3

3.20

3.55

u/ml

0.12

100

654

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

163

1138

1.43

4.64

1.6

1.7

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

523

1.64

4.61

2.0

2.4

25.35

115.59

ug/l

0.93

494

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

268

2031

1.32

4.60

1.2

1.1

—

(3003181) Sodium [Moles/volume] in Urine

201

1459

1.38

4.58

2.2

1.6

68.23

64.09

mmol/l

0.66

166

1164

(3003338) MCHC [Mass/volume]

10307

100447

1.09

4.54

18.1

14.9

333.29

332.99

g/l

2.69

10247

99697

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

565

4685

1.21

4.52

2.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

551

4560

1.21

4.50

8.1

5.0

24.40

24.52

mmol/l

0.55

524

4324

(3049717) Cytology report of Urine Cyto stain

346

2721

1.27

4.50

2.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

8958

86803

1.08

4.49

3.5

3.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1210

10675

1.14

4.49

2.0

1.9

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

400

1.72

4.44

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

293

1.84

4.34

1.1

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

446

3628

1.23

4.33

6.0

4.0

49.20

49.89

0.23

436

3582

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

261

1990

1.31

4.32

1.1

—

(3020891) Body temperature

420

3398

1.24

4.29

5.7

4.8

—

(3026389) Candida sp identified in Specimen by Organism specific culture

228

1708

1.34

4.27

1.4

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

396

3186

1.25

4.26

3.2

2.7

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

151

2.18

4.24

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

512

1.62

4.24

1.6

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

110

730

1.50

4.10

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

277

2149

1.29

4.05

2.2

2.1

0.00

g/l

0.79

251

1966

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

125

854

1.46

4.05

1.5

32.49

34.48

0.21

512

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

457

1.64

4.05

1.6

1.5

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

273

2117

1.29

4.01

2.2

2.1

0.00

g/l

-0.00

250

1962

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

497

1.61

4.00

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

212

1589

1.33

3.99

1.7

653.33

2219.39

titre

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

273

1.83

3.97

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

149

2.14

3.96

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

3546

33285

1.08

3.95

2.4

2.3

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

446

1.63

3.91

1.4

1.5

6.75

4.03

0.29

103

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

3.77

3.86

1.7

2.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

135

945

1.43

3.86

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

463

1.62

3.86

1.6

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

135

946

1.43

3.84

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

296

2333

1.27

3.84

2.1

0.02

g/l

0.09

269

2142

(21494814) CD8 cells/100 lymphocytes in Specimen

410

1.66

3.84

2.3

2.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

123

848

1.45

3.82

1.5

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

135

948

1.42

3.80

1.2

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

351

1.71

3.79

1.4

1.2

24.89

16.78

—

(3008898) HLA-B27 [Presence]

566

4779

1.19

3.78

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

3186

29825

1.08

3.78

2.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

264

1.81

3.75

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

264

1.81

3.75

1.1

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

264

1.81

3.75

1.1

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

298

2360

1.26

3.73

2.1

2.0

38.67

38.22

g/l

0.63

267

2090

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

289

2281

1.27

3.72

1.3

1.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

135

953

1.42

3.71

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

547

1.55

3.69

3.7

2.3

232.08

171.18

umol/l

0.56

272

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

135

954

1.41

3.69

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

319

2551

1.25

3.68

1.4

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

135

955

1.41

3.67

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

324

2597

1.25

3.66

2.2

0.79

0.75

g/l

0.06

282

2266

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

162

1184

1.37

3.63

7.6

6.8

11.08

11.02

mg/l

0.06

148

1102

(3044941) Cell count panel - Synovial fluid

188

1406

1.34

3.63

1.4

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

3.99

3.57

1.2

1.4

—

(44813793) Dust mix specific IgE antibody measurement

139

994

1.40

3.56

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

228

1759

1.30

3.54

1.5

—

(3016228) CD19 cells/100 cells in Blood

420

1.62

3.53

2.4

2.1

8.50

8.91

0.13

408

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

198

1499

1.32

3.53

1.3

1.2

0.19

0.23

nmol/l

0.23

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

350

2844

1.23

3.51

1.7

1.4

275.87

253.17

u/ml

0.53

212

1752

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

330

2667

1.24

3.48

1.7

1.8

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

875

9847

0.88

3.46

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

225

1739

1.29

3.45

2.9

3.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

165

1.99

3.44

1.8

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

526

4457

1.18

3.41

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

289

2308

1.25

3.40

3.0

3.1

47.90

76.65

mg/l

0.60

202

1868

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

282

2246

1.26

3.40

2.8

3.1

3.83

2.68

ratio

0.16

210

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

140

1013

1.38

3.37

1.7

1.8

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.38

3.35

1.0

1.2

1.41

1.76

umol/24h

1.62

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

606

5208

1.17

3.31

1.9

1.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

294

2361

1.25

3.31

1.3

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

193

1471

1.31

3.30

1.3

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

343

1.66

3.30

2.2

2.9

28.04

28.25

umol/l

0.05

249

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1145

10279

1.12

3.26

1.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

314

1.68

3.25

2.5

2.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

149

1096

1.36

3.25

4.0

10.6

7.12

7.38

mmol/l

0.35

124

907

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

8.54

3.25

3.7

5.6

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

246

1941

1.27

3.23

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

287

2306

1.24

3.23

3.0

3.1

42.62

46.41

mg/l

0.11

201

1869

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

117

828

1.41

3.22

1.3

186.34

183.94

pmol/l

0.04

117

828

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

2.77

3.22

2.0

1.5

20.07

24.68

nmol/l

0.15

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

376

3109

1.21

3.21

2.0

1.9

3.94

2.08

ug/l

1.04

329

2769

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

204

1576

1.29

3.18

2.5

2.6

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

456

3843

1.19

3.17

2.0

1.8

1.47

g/l

0.02

386

3317

(3042733) HLA Ab [Presence] in Serum

401

1.59

3.17

4.9

4.7

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

116

823

1.41

3.16

11.6

11.8

0.66

0.60

mmol/l

1.17

107

760

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

594

5120

1.16

3.14

1.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1735

15947

1.10

3.13

1.9

1.7

1.39

1.40

0.06

1538

14269

(3010503) CD19 cells [#/volume] in Blood

635

1.46

3.12

3.0

2.7

0.16

0.28

e9/l

0.90

617

(3023183) Ammonium ion [Moles/volume] in Plasma

258

2059

1.25

3.10

3.6

2.9

35.53

34.28

umol/l

0.36

239

1895

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.42

3.08

3.7

3.8

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

111

2.16

3.08

1.1

—

(3018405) Lactate [Moles/volume] in Arterial blood

354

2923

1.21

3.08

3.9

4.0

1.33

1.38

mmol/l

0.45

347

2869

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

491

1.52

3.08

1.2

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

232

1830

1.27

3.08

1.1

118.07

117.05

0.20

199

1662

(3007566) Smooth muscle Ab [Titer] in Serum

384

3198

1.20

3.06

1.2

1.3

83.61

128.96

titre

1.25

309

(3034770) Mitochondria Ab [Titer] in Serum

377

3135

1.20

3.05

1.2

1.3

709.09

980.30

titre

0.47

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

532

4559

1.17

3.04

11.3

10.2

24.15

24.20

mmol/l

0.17

517

4439

(3020874) Milk IgE Ab [Units/volume] in Serum

144

1067

1.35

3.03

1.1

1.2

4.42

2.75

u/ml

0.34

459

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

422

1.56

3.02

1.1

107.64

434.54

ng/l

0.83

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

109

772

1.41

3.01

4.0

3.9

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

116

831

1.39

3.01

1.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2583

24183

1.08

3.00

1.7

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

363

3014

1.21

3.00

1.6

1.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

423

1.56

2.99

1.3

1.2

110.24

108.98

0.11

379

(3025886) Oxalate [Mass/time] in 24 hour Urine

3.54

2.97

1.4

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

238

1893

1.26

2.96

1.2

1.3

2.99

4.24

u/ml

2.33

112

845

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1423

12997

1.10

2.94

2.8

0.70

0.72

ug/l

0.25

873

7960

(3024891) Influenza virus A+B Ag [Presence] in Specimen

393

3298

1.19

2.90

1.2

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

241

1926

1.25

2.88

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

135

1.99

2.86

1.0

—

(3021788) Differential panel - Synovial fluid

214

1690

1.27

2.84

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

363

3033

1.20

2.82

1.1

3.40

6.31

u/ml

4.86

200

1717

(3008401) Mugwort IgE Ab [Units/volume] in Serum

349

2906

1.20

2.82

1.1

0.81

1.24

u/ml

0.82

159

1411

(3004809) Band form neutrophils/100 leukocytes in Blood

192

1499

1.28

2.80

3.6

3.4

1.14

1.48

1.07

168

1357

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

174

1342

1.30

2.79

1.3

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

193

1.81

2.79

2.5

2.6

—

(3011288) Drugs identified in Urine by Screen method

583

5073

1.15

2.76

2.9

2.8

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

195

1.79

2.71

1.1

1.0

0.18

0.13

u/ml

0.12

119

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.35

2.69

1.1

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1449

13305

1.09

2.69

2.2

2.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

403

1.53

2.68

1.7

1.5

13.94

14.68

pmol/l

0.56

339

(3008037) Lactate [Moles/volume] in Venous blood

210

1669

1.26

2.67

3.8

3.0

1.44

1.54

mmol/l

0.82

200

1626

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

182

1.81

2.65

1.1

1.2

0.49

72.78

mg/l

1.20

133

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

182

1.81

2.65

1.1

1.0

0.01

0.16

u/ml

0.54

112

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

285

2344

1.22

2.64

1.4

25.42

25.02

u/l

0.06

228

1944

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

398

3376

1.18

2.63

1.2

1.1

1.48

2.59

u/ml

3.00

208

1829

(3002256) Pathology report gross observation

1441

13247

1.09

2.61

1.3

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

239

1935

1.23

2.59

1.7

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

3.32

2.58

1.1

1.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

4.65

2.58

1.0

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

811

7246

1.12

2.57

1.3

1.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

303

2515

1.20

2.57

1.4

1.3

4.00

4.04

ug/l

0.03

279

2308

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

141

1.91

2.56

2.0

1.8

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

464

1.48

2.56

1.3

1.2

0.31

0.30

g/l

0.61

374

(3027540) Rickettsia typhi Ab [Titer] in Serum

3.99

2.55

1.1

1.0

—

(3028433) Virus identified in Specimen by Culture

384

1.53

2.55

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

647

1.40

2.52

1.1

1619.54

1506.98

miu/ml

0.42

647

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

117

868

1.35

2.51

1.2

1.3

0.92

3.04

u/ml

4.14

491

(3002523) Influenza virus A Ag [Presence] in Specimen

286

2368

1.21

2.50

1.1

—

(3017704) Immunofixation for Urine

387

1.52

2.47

1.3

1.7

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

266

2192

1.21

2.45

1.1

8.97

11.11

au/ml

0.24

128

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

114

847

1.34

2.43

1.4

11.10

11.50

umol/l

0.28

105

811

(3014051) Protein [Presence] in Urine by Test strip

223

2709

0.82

2.36

2.5

2.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

514

1.44

2.36

1.7

1.8

1.15

1.25

nmol/l

0.33

400

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

589

1.41

2.35

1.0

96.84

94.01

0.38

474

(3011648) Oxygen content in Venous blood

112

835

1.34

2.35

9.8

5.7

11.41

11.25

0.18

112

835

(3003740) Influenza virus B Ag [Presence] in Specimen

284

2366

1.20

2.35

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.06

2.34

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

243

1.64

2.33

1.4

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

136

1044

1.30

2.33

1.1

4.09

8.18

u/ml

0.46

367

(3019225) pH of Specimen

974

8843

1.10

2.32

4.1

4.0

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

228

1.66

2.32

1.3

46.11

38.63

0.68

154

(3051593) INR in Capillary blood by Coagulation assay

306

1.56

2.30

8.5

9.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

154

1.81

2.30

1.6

1.4

20.00

16.87

nmol/l

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

427

1.47

2.29

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

245

2019

1.21

2.28

1.1

2.85

3.51

u/ml

0.21

104

1009

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

104

772

1.34

2.26

1.4

1.3

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.47

2.25

1.3

1.4

3.42

3.06

mu/l

—

(3037756) Immunofixation for Serum or Plasma

187

1501

1.24

2.24

1.4

1.7

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

123

937

1.31

2.24

1.1

0.29

1.43

u/ml

1.50

324

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

654

1.37

2.24

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

163

1288

1.26

2.24

1.4

1.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

318

2690

1.18

2.23

5.8

4.3

0.34

u/ml

0.05

181

1513

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

498

4360

1.14

2.22

1.4

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

156

1.79

2.22

3.9

3.6

8.69

5.88

0.34

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

483

5470

0.88

2.21

1.4

1.5

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

201

1.69

2.20

2.3

2.8

48.95

31.53

mg/l

0.32

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

302

1.55

2.20

1.2

1.1

95.62

82.54

0.57

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

167

1327

1.26

2.19

2.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

781

0.67

2.19

1.0

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

2.85

2.19

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

262

2185

1.20

2.17

1.1

7.39

6.55

u/ml

0.13

112

976

(44816559) Phosphatidylethanol [Mass/volume] in Blood

296

2497

1.18

2.16

1.3

1.4

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

233

1.63

2.16

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

233

1.63

2.16

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

233

1.63

2.16

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

233

1.63

2.16

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

642

1.37

2.15

1.4

1.5

5.01

6.12

u/l

1.87

550

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

486

4265

1.14

2.11

1.6

1.7

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

435

1.44

2.11

1.3

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

231

1910

1.21

2.10

1.0

1.1

0.64

0.44

u/ml

0.21

566

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

162

1291

1.25

2.09

1.4

1.5

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

130

1.84

2.09

2.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

167

1336

1.25

2.09

1.6

1.7

—

(3002079) Sodium [Moles/time] in 24 hour Urine

503

1.41

2.07

1.2

1.3

146.82

157.62

mmol/24h

0.58

503

(3005988) Vibrio sp identified in Specimen by Organism specific culture

162

1293

1.25

2.07

1.4

1.5

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.13

2.06

2.3

6.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

138

1.81

2.06

1.9

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

166

1330

1.25

2.05

1.4

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

364

1.48

2.05

1.7

1.5

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

648

1.35

2.04

1.9

1.6

—

(3018291) Platelet Ab [Presence] in Serum

3.98

2.03

1.0

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

108

822

1.31

2.01

2.4

2.7

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

583

1.37

1.99

1.5

1.6

1084299.20

1696007.51

iu/ml

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.49

1.99

1.3

2.5

—

(3038515) Glucose [Moles/volume] in Venous blood

190

1551

1.22

1.99

4.0

3.0

7.46

7.35

mmol/l

0.18

182

1516

(3032641) Amino acids panel - Urine

2.62

1.99

1.1

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

139

1096

1.27

1.98

2.4

2.0

22.21

25.85

mg/l

0.40

296

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

441

1.42

1.98

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

105

799

1.31

1.97

1.1

1.05

1.06

ratio

0.32

275

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

279

1.54

1.96

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

279

1.54

1.96

1.2

—

(3012989) Citrate [Moles/time] in 24 hour Urine

3.32

1.95

1.9

1.4

2.19

2.00

mmol/24h

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2121

20029

1.06

1.93

2.3

2.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

127

995

1.27

1.92

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.18

1.92

1.1

1.7

42.14

43.22

umol/l

0.04

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

445

1.41

1.90

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

157

1.71

1.89

1.4

1.7

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

556

1.36

1.87

1.3

1.5

23.77

19.49

u/ml

0.60

116

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

454

5095

0.88

1.86

1.4

—

(21494434) Karyotype in Bone marrow

746

1.31

1.85

1.1

1.2

—

(3041354) Potassium [Moles/volume] in Venous blood

116

904

1.28

1.84

2.8

2.2

4.08

4.03

mmol/l

0.63

116

894

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

454

5091

0.88

1.84

1.4

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

440

1.41

1.83

1.6

1.4

72.46

152.99

nmol/24h

1.34

440

(3009871) Measles virus Ab [Titer] in Serum

432

1.41

1.82

1.8

1.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

160

1298

1.23

1.81

1.4

1.5

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.26

1.78

1.9

1.6

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

476

1.38

1.78

1.9

2.3

10.11

9.41

mg/l

0.54

390

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

160

1301

1.23

1.78

1.4

1.5

—

(3004775) Volume in Urine collected for unspecified duration

639

1.33

1.77

2.3

686.37

638.25

0.45

463

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

385

1.42

1.76

3.0

2.7

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

453

5063

0.89

1.75

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

255

2170

1.17

1.74

1.7

1.6

8128.02

13195.70

e6/l

1.58

183

1571

(3035285) Chloride [Moles/volume] in Venous blood

115

903

1.27

1.74

2.8

2.2

105.97

105.53

mmol/l

0.48

115

893

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

378

1.42

1.73

2.6

2.4

168.88

118.54

ng/l

0.38

249

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2317

22014

1.06

1.73

2.4

2.2

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.49

1.73

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

371

1.42

1.71

4.2

4.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

110

1.81

1.70

1.2

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

112

881

1.27

1.68

2.8

2.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

338

3836

0.87

1.68

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

456

5079

0.89

1.68

1.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

275

2363

1.16

1.68

1.1

7.60

4.76

u/ml

0.47

131

1224

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

410

3623

1.13

1.67

1.9

1.8

—

(3050794) Legionella sp Ab [Presence] in Serum

1.94

1.67

1.2

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

475

1.36

1.65

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.79

1.64

1.0

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

384

1.40

1.61

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

460

1.37

1.61

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

618

5603

1.10

1.61

1.6

1.5

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.83

1.59

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

302

1.45

1.59

1.2

1.1

90.50

72.89

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

229

1.52

1.59

5.1

7.0

—

(3052592) Norovirus Ag [Presence] in Stool

159

1.63

1.56

1.2

1.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.84

1.54

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

152

1.64

1.53

1.3

1.1

5.78

4.64

pmol/l

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

231

1.51

1.53

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

635

5785

1.10

1.51

2.5

2.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

241

2070

1.16

1.51

2.2

2.3

0.88

0.81

nmol/l

0.69

203

1754

(3004616) Nuclear Ab [Presence] in Serum

154

1273

1.21

1.50

1.4

1.3

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.58

1.50

1.0

1.8

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

290

1.44

1.49

1.4

1.6

9.33

8.73

ug/l

0.49

290

(3036782) Glucose [Moles/volume] in Pleural fluid

667

1.29

1.48

1.3

6.34

6.27

mmol/l

0.09

613

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

545

1.32

1.48

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

545

1.32

1.48

5.4

6.1

40.27

6395.94

u/ml

0.58

112

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

209

1.53

1.48

1.1

0.02

1.19

u/ml

1.50

113

(3022493) Free Hemoglobin [Mass/volume] in Plasma

468

1.34

1.47

6.3

5.5

69.79

850.42

mg/l

0.78

354

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

131

1.67

1.47

1.2

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

162

1.60

1.46

1.0

1.1

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

124

1.69

1.44

1.0

0.52

1.50

u/ml

0.45

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

109

1.74

1.44

1.1

—

(3017732) Neutrophils [#/volume] in Blood

837

7737

1.08

1.44

2.4

2.6

4.93

4.60

e9/l

0.27

692

6502

(3037692) Legionella sp identified in Specimen by Organism specific culture

309

1.42

1.44

1.5

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

522

1.32

1.43

1.2

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

132

1.66

1.43

1.4

69.67

58.16

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

462

1.34

1.43

1.6

2.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

462

1.34

1.43

1.6

2.0

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

211

1.51

1.43

1.1

0.08

2.55

u/ml

0.79

112

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

488

1.33

1.42

1.1

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

159

1327

1.20

1.42

1.1

96.91

95.29

0.32

141

1253

(3043238) Trisomy 21 risk [Likelihood] in Fetus

372

4143

0.89

1.42

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

100

796

1.25

1.41

1.5

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

100

796

1.25

1.41

1.5

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

100

796

1.25

1.41

1.5

1.8

—

(3016750) Collection duration of Urine

489

1.33

1.41

2.2

510.08

501.35

min

0.25

385

(3006442) Creatine [Moles/volume] in Serum or Plasma

753

1.26

1.39

1.3

1.4

93.01

78.24

umol/l

0.42

753

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

276

2413

1.14

1.38

1.3

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

578

5270

1.10

1.38

1.5

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

197

1.52

1.37

1.9

1.7

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

115

934

1.23

1.36

1.1

7.72

7.64

iu/ml

0.01

213

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

466

1.33

1.36

1.3

9.05

12.70

u/l

3.05

434

(3010144) Erythrocytes [#/volume] in Synovial fluid

103

827

1.24

1.36

1.4

70334.42

91059.56

e6/l

0.24

575

(3032352) Blasts [#/volume] in Cerebral spinal fluid

142

1.61

1.36

3.7

3.9

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

2.93

1.35

1.2

0.96

1.51

mg/l

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

174

1.55

1.34

1.5

1.9

18.40

45.07

pmol/l

3.46

149

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

405

4472

0.90

1.34

1.7

1.8

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

223

1.48

1.33

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

930

0.78

1.32

2.2

1.8

—

(4035726) Immunohistochemistry procedure

904

8414

1.08

1.32

1.5

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

201

1724

1.16

1.32

1.5

1.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

340

3023

1.12

1.32

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.96

1.31

4.5

5.3

—

(21494755) Public health laboratory ask at order entry panel

1351

14189

0.94

1.30

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

681

1.26

1.29

5.0

6.6

—

(3051101) Glucose [Moles/volume] in Cord blood

130

0.46

1.28

2.7

6.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

250

1.44

1.27

5.7

6.9

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.88

1.27

1.2

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

113

1362

0.82

1.26

1.6

1.5

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

186

1.50

1.24

1.0

1.1

1.12

0.34

u/ml

0.36

101

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

277

1.40

1.23

1.0

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

326

2907

1.12

1.23

1.1

2.26

2.44

u/ml

0.11

167

1621

(3047352) Trisomy 18 risk [Likelihood] in Fetus

367

4049

0.90

1.22

1.4

1.5

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

131

1.60

1.21

1.2

1.1

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.62

1.21

1.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2638

25382

1.04

1.21

2.4

2.2

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

2.03

1.20

1.3

1.4

6.00

0.50

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.96

1.20

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

437

3964

1.10

1.20

2.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.10

1.17

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.92

1.15

2.0

1.6

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

173

1.50

1.15

1.4

1.6

61.58

61.74

ng/l

0.00

105

(3024869) Neuronal Ab [Presence] in Serum

149

1.54

1.15

1.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

129

1083

1.19

1.14

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

111

919

1.20

1.14

1.2

1.1

—

(3017509) Phencyclidine [Presence] in Urine

190

1.47

1.14

2.7

1.8

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.80

1.13

1.2

1.4

390.00

311.18

umol/24h

0.34

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

766

1.22

1.13

1.3

1.2

95.00

69.41

u/ml

—

(3005033) Fetal Nuchal fold Thickness US

368

4036

0.91

1.12

1.4

1.5

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

500

1.28

1.11

1.1

75.79

83.45

u/l

0.36

454

(3008536) Aspergillus sp Ab [Presence] in Serum

208

1.44

1.10

1.9

2.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

580

5354

1.08

1.10

1.3

250.29

228.13

miu/ml

0.72

259

2624

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

422

1.30

1.09

1.1

—

(3042517) Benzodiazepines panel - Urine

200

1.45

1.09

3.3

2.3

—

(3038026) Centromere Ab [Units/volume] in Serum

788

1.21

1.09

1.4

1.2

17.30

43.98

u/ml

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

680

1.23

1.08

1.6

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

771

1.22

1.07

1.3

1.2

53.17

41.08

u/ml

0.24

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.81

1.07

1.3

1.2

—

(3045142) Bone marrow Pathology biopsy report

118

990

1.19

1.07

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

499

0.74

1.06

1.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

800

1.21

1.05

1.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

348

0.69

1.05

3.1

3.0

—

(40763791) Oxygen content in Venous blood by calculation

2.11

1.05

6.0

8.4

11.70

12.41

ml/dl

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

161

1.49

1.04

4.4

4.9

52.62

39.30

ug/min

0.47

113

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

738

1.22

1.04

1.3

1.2

2.22

11.86

u/ml

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

347

0.69

1.04

6.2

6.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

497

1.26

1.03

1.1

16.49

22.74

u/l

0.79

451

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

279

1.36

1.03

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

436

0.73

1.00

1.1

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

290

1.34

0.98

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.97

0.0

1.0

—

(3033799) Differential panel - Peritoneal fluid

259

0.65

0.97

2.9

2.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

422

1.28

0.96

1.1

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

156

1.47

0.96

11.3

14.4

0.46

0.38

umol/l

0.27

147

(3019977) pH of Arterial blood

468

1.26

0.94

3.3

2.9

7.43

0.30

147

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

258

1.35

0.94

1.1

8.84

3.04

u/ml

0.73

215

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

184

0.60

0.93

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.21

0.93

2.0

5.3

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.77

0.93

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

273

2459

1.11

0.92

2.7

2.4

8.00

6.87

umol/l

0.43

207

1828

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

651

6085

1.07

0.92

3.0

3.1

81.46

43.69

u/ml

0.39

631

5879

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

200

1.40

0.91

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

266

0.67

0.90

3.2

2.0

71195.18

16144.38

e6/l

0.58

143

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

252

1.34

0.89

1.2

1.8

28.57

34.64

u/l

0.16

234

(3016031) Almond IgE Ab [Units/volume] in Serum

159

1.44

0.89

1.1

0.55

1.24

u/ml

0.89

103

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

119

1019

1.16

0.89

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

261

1.34

0.89

1.1

1.3

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

590

1.22

0.88

1.1

33.44

25.36

u/ml

0.08

384

(3041918) Cholesterol [Moles/volume] in Pleural fluid

135

1.48

0.87

1.2

1.87

1.74

mmol/l

0.19

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.99

0.86

1.0

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

510

1.23

0.86

1.0

762.00

750.78

ng/l

0.07

357

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

746

1.19

0.86

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

601

1.21

0.85

1.4

1.3

294.56

383.44

u/l

1.31

575

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

169

1.42

0.85

1.5

1.6

74.57

124.30

ng/l

2.42

169

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.71

0.85

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

212

1.36

0.84

2.0

1.4

—

(3006270) Folate [Moles/volume] in Blood

785

1.18

0.84

1.1

375.34

390.62

nmol/l

0.32

703

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

120

1.49

0.83

1.1

5.15

22.03

u/ml

2.62

(4281824) Cell count and differential, peritoneal fluid

1099

0.85

0.83

1.2

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

513

1.22

0.83

1.0

45.00

42.48

ng/l

0.19

364

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.75

0.82

1.0

—

(40757494) Bilirubin.total [Moles/volume] in Blood

505

1.22

0.81

3.3

2.6

48.57

61.32

umol/l

—

(3020650) Glucose [Presence] in Urine

329

0.73

0.81

1.8

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.69

0.81

1.2

1.1

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

1.69

0.81

1.4

1.5

2.40

30.64

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.70

0.80

2.9

5.5

—

(3022621) pH of Urine by Test strip

707

6667

1.06

0.79

3.0

2.7

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.79

0.0

1.1

—

3.12

—

(3050129) First trimester maternal screen panel - Serum or Plasma

626

6602

0.94

0.78

1.5

1.4

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

106

1.50

0.77

1.2

3.75

2.06

mmol/l

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

509

1.21

0.77

1.0

345.02

319.84

ng/l

0.24

369

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

199

1.35

0.76

1.5

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

638

1.19

0.75

1.6

8.31

6.24

u/l

0.73

521

(3020191) Ethanol [Moles/volume] in Serum or Plasma

116

1008

1.15

0.75

1.7

1.5

1.36

1.35

promille

0.01

749

(3008757) Leukocyte morphology finding [Identifier] in Blood

122

1065

1.14

0.74

4.2

3.8

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

132

1.43

0.74

7.5

8.8

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

439

1.23

0.74

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.64

0.74

1.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

173

1545

1.12

0.73

1.2

1.3

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.84

0.73

1.0

—

(3034426) Prothrombin time (PT)

431

1.23

0.73

1.1

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

217

1963

1.10

0.73

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

175

1.37

0.73

1.9

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

1.99

0.72

1.0

1.4

118.20

75.00

e6/l

—

(3035933) Granulocytes/100 leukocytes in Blood

478

1.21

0.71

1.2

1.7

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

1.57

0.70

1.3

1.8

170.11

187.24

ng/l

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

931

0.86

0.70

1.0

1.1

280.31

289.00

mg/l

0.49

845

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

791

1.16

0.70

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

488

1.21

0.70

1.6

2.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

344

1.25

0.69

1.3

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

783

1.16

0.69

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

489

1.20

0.69

1.6

2.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

130

1148

1.13

0.68

3.9

4.5

107.43

115.23

u/ml

0.06

361

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

453

1.21

0.68

2.3

2.4

171.41

151.13

nmol/l

0.63

394

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

169

1.36

0.67

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

224

2040

1.10

0.67

4.8

3.7

—

(3014271) Vancomycin [Susceptibility]

337

1.24

0.66

2.7

2.8

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

161

1.36

0.66

1.2

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.62

0.66

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.53

0.66

1.0

1.3

—

(3000764) Benzodiazepines [Presence] in Urine

781

7434

1.05

0.65

2.4

2.0

—

(3016879) Cocaine [Presence] in Urine

725

6892

1.05

0.64

2.5

2.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

223

1.30

0.64

1.1

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

450

4755

0.94

0.64

1.5

1.6

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

340

1.23

0.63

3.6

3.3

—

(3025130) Human papilloma virus identified in Specimen

212

1935

1.09

0.62

1.6

1.8

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

155

1708

0.90

0.62

3.0

3.5

250.81

476.01

u/ml

0.54

140

1567

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

468

1.19

0.62

1.3

50.00

60.98

titre

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.63

0.61

1.3

1.0

—

(3001556) Androgen free Index in Serum or Plasma

190

1.31

0.61

1.1

1.2

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.60

0.0

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

1.45

0.60

1.4

1.3

204.00

402.25

u/l

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

859

1.14

0.60

1.1

—

(3045424) Erythrocytes [Presence] in Urine

197

1797

1.09

0.60

1.5

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

253

1.26

0.59

1.1

1.28

7.74

u/ml

2.18

212

(3025018) Bordetella pertussis Ab [Titer] in Serum

870

1.13

0.59

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

119

1059

1.12

0.58

1.2

88.65

64.03

u/l

0.38

108

954

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

582

1.16

0.58

1.4

—

(3006462) Nitrate [Presence] in Urine

517

0.83

0.58

3.5

2.8

—

(3028300) Cannabinoids [Presence] in Urine

784

7496

1.04

0.57

2.5

2.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

381

1.20

0.57

1.8

2.3

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

123

1.38

0.56

1.1

1.0

—

(3024932) HLA-DR beta [Type]

418

1.19

0.56

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

106

1.41

0.56

1.1

—

(3044007) Cell count panel - Peritoneal fluid

240

0.75

0.56

1.9

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

373

1.20

0.55

1.8

2.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

373

1.20

0.55

1.8

2.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

438

0.82

0.55

2.1

2.0

17.27

138.53

ug/min

1.32

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

511

1.17

0.55

1.0

11.03

14.17

u/ml

0.40

306

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

940

0.88

0.55

1.3

1.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

238

1.26

0.55

1.3

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

159

0.69

0.54

1.9

4.5

—

(3025577) Chromium [Mass/volume] in Blood

438

1.18

0.54

2.2

2.1

1.63

2.50

ug/l

2.13

372

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.53

0.54

1.7

1.3

—

(3030313) Adrenal Ab [Titer] in Serum

150

1.33

0.54

1.2

—

(3012898) Urea [Moles/volume] in Urine

116

1.37

0.53

1.3

1.6

170.06

164.42

mmol/l

0.05

109

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.53

0.52

15.3

9.5

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.45

0.52

2.8

2.9

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

1.51

0.51

1.3

1.2

1.68

1.64

mg/l

—

(3027008) Opiates [Presence] in Urine

780

7479

1.04

0.51

2.4

1.9

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

571

1.15

0.51

1.4

1.5

—

(40757373) Influenza virus identified in Isolate

187

1.28

0.51

2.0

1.5

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.40

0.51

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

488

1.16

0.50

1.3

745.71

435.16

titre

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

100

1.39

0.50

1.7

1.3

1.66

1.46

ml/s/173m2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

224

0.76

0.50

1.8

1.9

1.46

3.44

ug/l

—

129

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.38

0.50

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

215

1.25

0.49

1.7

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

235

2507

0.93

0.49

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

109

0.64

0.48

1.1

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.52

0.48

1.0

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

101

904

1.11

0.48

3.4

56.14

55.49

0.12

776

(3023487) Leukocytes [#/volume] in Peritoneal fluid

299

0.80

0.47

3.2

2.2

16926.06

3374.89

e6/l

0.36

207

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.39

0.47

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

558

1.14

0.46

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.42

0.45

1.1

1.0

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

155

1.29

0.45

1.1

2.87

2.54

u/ml

0.05

105

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

175

0.74

0.45

1.2

—

(4034850) Laboratory test

348

3287

1.06

0.45

7.8

8.5

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

550

1.14

0.45

2.9

3.1

136.27

138.07

au/ml

0.01

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1405

13650

1.03

0.45

1.8

—

(3000330) Specific gravity of Urine by Test strip

438

4568

0.95

0.44

3.8

3.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

273

1.20

0.44

3.8

3.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

273

1.20

0.44

3.8

3.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

107

967

1.10

0.44

1.5

1.4

29.78

31.73

nmol/l

0.31

889

(3002619) Bacteria identified in Specimen by Culture

237

1.22

0.43

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

599

1.13

0.43

3.4

3.8

9.27

8.13

mg/l

0.77

486

(3029396) Erythrocyte agglutination [Presence] in Blood

510

0.86

0.43

2.7

3.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1863

18179

1.02

0.43

1.7

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

394

1.16

0.43

1.1

0.43

5.79

u/ml

1.35

351

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

553

1.14

0.42

1.1

228.73

184.71

iu/ml

0.34

548

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.42

0.42

1.1

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.56

0.42

1.0

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.56

0.42

5.6

8.2

—

(3044927) Protein electrophoresis panel - Urine

714

1.12

0.42

1.1

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.37

0.41

2.1

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

876

0.90

0.41

3.1

2.9

24.30

55.17

mg/l

1.66

640

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.51

0.41

1.0

1.2

—

(3024471) HLA-A [Type]

424

1.15

0.41

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

149

1.27

0.40

7.4

7.5

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.46

0.40

1.4

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

105

1.33

0.40

1.3

1.5

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

193

0.77

0.40

1.1

1.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1619

16464

0.98

0.40

1.5

—

(3035880) pH of Pleural fluid

370

1.16

0.39

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

589

0.88

0.39

2.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

217

2035

1.06

0.38

2.5

2.3

120.42

110.76

ug/min

0.13

118

1277

(3003157) Bacteria [#/volume] in Mother's milk

1.38

0.38

7.2

7.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

209

1961

1.06

0.37

1.2

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.30

0.37

1.2

1.1

3.87

9.31

mg/l

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

109

998

1.09

0.36

1.2

1.3

102.86

195.48

titre

2.56

186

(3012441) Differential panel - Pleural fluid

712

1.11

0.36

1.4

1.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

116

1.29

0.36

10.7

10.3

7.96

5.67

mmol/l

0.64

116

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

123

0.73

0.35

4.2

3.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

372

0.86

0.35

2.4

2.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

177

0.79

0.34

1.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.33

0.33

1.0

1.3

214.98

564.43

nmol/l

—

(21494890) Protein electrophoresis panel - 24 hour Urine

779

0.91

0.33

2.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

395

1.14

0.33

2.3

2.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

902

1.08

0.31

1.5

33.41

34.14

g/l

0.25

819

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

588

0.90

0.31

1.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

644

1.10

0.31

1.1

1.2

2.33

14.07

u/ml

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

104

1116

0.93

0.30

1.5

1.4

—

titre

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

183

1.20

0.30

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

691

0.91

0.30

1.2

—

(3003694) ABO and Rh group [Type] in Blood

3470

34915

0.99

0.29

1.5

1.6

—

(40768793) Breast Pathology biopsy report

254

2419

1.05

0.29

1.3

—

(40768795) Lymph node Pathology biopsy report

108

1002

1.07

0.29

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

155

1632

0.95

0.27

1.7

1.6

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.25

0.27

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

227

2161

1.05

0.27

3.5

3.2

25.48

25.89

mg/l

0.06

145

1319

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

850

8651

0.98

0.26

3.7

4.1

22.88

25.60

ug/l

0.08

627

6807

(3045414) Leukocytes [Presence] in Urine

467

4791

0.97

0.26

1.8

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

122

1.22

0.26

1.0

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

102

950

1.07

0.26

2.8

2.5

1.15

1.42

g/24h

0.74

485

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

187

1.17

0.25

1.2

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

404

1.11

0.25

4.2

3.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

250

2393

1.04

0.24

1.7

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1209

12243

0.98

0.24

1.7

1.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

101

944

1.07

0.24

1.5

1.7

—

(3008607) Semen analysis panel

1.25

0.23

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

245

1.14

0.23

1.0

1.2

36.65

39.24

g/l

0.26

135

(3019174) dRVVT (LA screen)

125

0.80

0.23

1.1

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

146

1382

1.05

0.23

1.3

52.48

32.67

u/l

0.42

128

1208

(3027944) Amphetamines [Presence] in Urine

756

7374

1.02

0.23

2.4

1.9

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

264

1.13

0.23

2.0

2.4

2.05

1.69

mmol/l

0.28

197

(3001019) Free T4 and TSH panel - Serum or Plasma

766

7473

1.02

0.23

1.7

1.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

107

1131

0.94

0.23

3.3

3.1

0.87

0.82

nmol/l

0.47

849

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

106

994

1.06

0.23

1.7

2.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

124

1.21

0.23

2.1

1.8

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.28

0.22

1.0

1.2

201.20

297.73

nmol/l

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

398

1.10

0.22

1.0

1.1

—

(3013762) Body weight Measured

1.25

0.22

1.0

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

903

0.94

0.22

1.6

1.5

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

209

1.14

0.21

1.5

1.6

0.67

0.41

ug/l

0.75

144

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.26

0.21

6.3

4.8

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

189

1961

0.96

0.21

2.1

2.3

13.15

13.10

0.31

184

1937

(3045788) Cell count panel - Pleural fluid

650

1.07

0.21

1.5

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.25

0.20

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

181

1876

0.96

0.20

1.3

1.4

6.59

6.91

mmol/l

1.15

159

1692

(40768800) Prostate Pathology biopsy report

121

1266

0.95

0.20

1.2

—

(3017569) Oxygen content in Arterial blood

363

1.10

0.20

2.5

2.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

224

2311

0.96

0.20

1.2

1.3

—

(40758292) HTLV I+II Ab panel - Serum

211

1.13

0.19

1.2

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

106

1003

1.05

0.19

1.2

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

185

0.86

0.19

1.1

1.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.23

0.18

1.4

1.3

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

423

1.08

0.18

1.2

37.76

8.42

u/ml

0.64

321

(3009677) Dengue virus Ab [Presence] in Serum

1.20

0.18

1.1

1.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

109

1.19

0.18

1.5

1.4

4.86

11.60

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.16

0.17

1.0

1.1

—

(3024263) Appearance of Synovial fluid

502

1.07

0.17

1.6

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

813

1.05

0.16

2.9

2.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1158

11392

1.01

0.16

4.1

3.9

32.06

32.14

0.09

833

8235

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.09

0.15

1.1

1.2

—

(3026726) Creatinine [Moles/volume] in Specimen

0.79

0.15

2.0

2.5

139.33

455.68

umol/l

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

302

1.09

0.15

1.6

1.7

—

(3022475) Manganese [Moles/volume] in Blood

1.11

0.15

1.3

—

(3014891) Appearance of Pleural fluid

0.79

0.14

1.3

1.2

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

140

1.14

0.14

1.1

2.58

9.65

u/ml

—

(3020491) Glucose [Moles/volume] in Blood

818

1.05

0.14

2.0

1.9

6.92

6.24

mmol/l

1.06

618

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

217

1.10

0.13

1.6

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

179

1.11

0.13

2.0

2.3

7.22

7.28

mmol/l

0.04

(3007542) Rye IgE Ab [Units/volume] in Serum

1.19

0.13

1.1

1.0

0.05

0.32

u/ml

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

610

0.95

0.13

1.2

1.3

—

(3006598) pH of Arterial cord blood

276

1.08

0.12

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

276

1.08

0.12

1.0

-4.50

-2.13

mmol/l

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

276

1.08

0.12

1.0

7.13

7.35

kpa

0.30

230

(3032868) Hemoglobin electrophoresis panel in Blood

132

1.13

0.12

1.7

1.6

—

(3022670) pH of Venous cord blood

1.17

0.12

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

112

1152

0.97

0.11

1.2

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

166

0.90

0.10

2.8

696.93

2746.39

u/l

1.17

153

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

166

0.90

0.10

1.5

1.3

—

(3048879) Bone marrow aspiration report

211

1.09

0.10

2.3

—

(40762814) Titanium [Mass/volume] in Blood

115

1.13

0.10

2.5

2.3

2.70

4.25

ug/l

—

(40760410) HLA-B [Type] by High resolution

1.11

0.09

1.0

—

(40760409) HLA-A [Type] by High resolution

1.11

0.09

1.0

—

(40763590) HLA-DQ beta [Type]

1.11

0.09

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.11

0.09

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

173

1.09

0.09

1.4

1.3

—

(3013862) HLA-DP [Type]

1.08

0.09

1.0

—

(3036180) Methadone [Presence] in Urine

848

1.03

0.09

3.1

2.5

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.04

0.09

1.0

1.3

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

226

0.93

0.09

1.4

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

741

1.04

0.09

1.4

39840.17

55059.31

e6/l

0.30

435

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.07

0.08

1.2

1.1

8.46

8.27

mmol/l

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

1.05

0.08

3.3

1.6

18.17

17.22

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

187

1899

0.98

0.08

1.1

113.21

5597.92

iu/ml

0.63

485

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

752

0.97

0.08

1.2

1.3

1.53

1.55

g/l

0.39

752

(3043410) Blood group antigens tested for on Red Blood Cells

276

0.94

0.08

1.3

1.7

—

(3007463) Buprenorphine [Presence] in Urine

0.82

0.07

6.8

5.1

—

(3001729) Color of Synovial fluid

0.81

0.07

1.8

1.5

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.80

0.07

1.0

1.1

8.73

13.49

u/l

—

(4212803) Bone marrow aspirate examination

1.06

0.07

1.3

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

122

0.90

0.07

1.2

—

(3015183) Erythrocyte sedimentation rate

686

1.03

0.07

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

450

1.04

0.07

1.4

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

450

1.04

0.07

1.4

1.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

108

1.11

0.06

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

668

1.03

0.06

1.1

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

276

2782

0.99

0.06

1.5

76.06

121.22

pmol/l

3.90

265

2707

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.11

0.06

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

151

0.92

0.06

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

748

1.03

0.05

1.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

120

0.91

0.05

1.2

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

169

1707

0.99

0.05

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

858

1.02

0.05

1.5

1.4

1.41

1.46

nmol/l

0.20

770

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

178

1.06

0.05

1.3

1.2

8.58

393.63

ug/l

—

(40768441) Liver Pathology biopsy report

829

1.02

0.05

1.4

1.5

—

(40768806) Pleura Pathology biopsy report

733

0.98

0.04

1.6

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

113

1108

1.02

0.04

1.1

—

(3000285) Sodium [Moles/volume] in Blood

101

1.08

0.03

1.5

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

620

0.98

0.03

1.3

1.2

88.50

84.01

u/l

0.07

547

(3044009) aPTT.lupus sensitive (LA screen)

121

1.07

0.03

1.1

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

158

1558

1.01

0.03

1.1

1.45

1.49

g/l

0.56

140

1424

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

312

3088

1.01

0.03

3.0

3.6

188.99

2027.37

u/ml

1.30

265

2633

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

369

1.03

0.02

2.9

2.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

598

0.98

0.02

1.3

1.2

15.02

20.10

u/l

0.95

514

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

736

0.99

0.01

1.3

1.4

5.50

5.48

mmol/l

0.06

696

(3010937) Rubella virus Ab [Presence] in Serum

103

1.06

0.01

1.2

1.1

—

(3022689) Creatine [Moles/volume] in Urine

276

0.97

0.01

1.3

1.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

216

0.97

0.01

1.2

1.4

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

146

0.96

0.01

1.6

5.9

—

(4146454) Self-monitoring of blood glucose

824

0.99

0.01

3.2

2.7

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

839

8367

1.00

0.01

1.4

—

(3047189) Immunofixation for 24 hour Urine

335

0.98

0.00

1.7

1.8

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

611

1.01

0.00

1.1

4.94

12.27

u/ml

2.79

113

(40765096) Chromosome analysis panel by Banding

263

0.98

0.00

1.2

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

710

1.00

0.00

2.6

1.9

1.61

1.81

u/field

0.12

326

(3038177) Helicobacter pylori Ab [Presence] in Serum

210

2088

1.00

0.00

1.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

105

0.95

0.00

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

832

1.01

0.00

1.5

1.4

3294.81

2474.44

e6/l

0.17

605

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

529

1.00

0.00

1.6

1.29

2.86

u/field

1.96

380

(3003577) Lead [Moles/volume] in Blood

0.94

-0.00

1.0

1.3

—

0.21

—

(3009179) Lactate [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.0

—

1.82

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.95

-0.00

1.1

1.3

—

526.17

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

0.91

-0.00

1.0

1.1

—

2.02

—

(36304079) Mucus [Presence] in Urine sediment

0.00

-0.00

0.0

1.0

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

-0.00

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.9

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.01

-0.00

3.0

2.1

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

-0.00

0.0

1.2

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

6.8

—

15.00

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

30.35

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.90

-0.00

1.1

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

4.0

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

-0.00

0.0

1.0

—

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

0.00

-0.00

0.0

2.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint H7_REFRAACCOMMODIS and mortality.

Females

Parameter	HR [95% CI]	p-value
H7_REFRAACCOMMODIS	1.15 [1.03, 1.29]	0.016
Birth year	0.996 [0.99, 1.0]	0.323

During the follow-up period (1.1.1998 — 31.12.2019), 2935 out of 56112 females with H7_REFRAACCOMMODIS died.

Males

Parameter	HR [95% CI]	p-value
H7_REFRAACCOMMODIS	1.248 [1.09, 1.43]	0.001
Birth year	0.985 [0.98, 0.99]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 2510 out of 44720 males with H7_REFRAACCOMMODIS died.

Mortality risk

Mortality risk for people of age

years, who have H7_REFRAACCOMMODIS.

N-year risk	Females	Males
1	0.114%	0.227%
5	0.712%	1.458%
10	1.848%	3.313%
15	3.315%	6.2%
20	5.755%	10.422%

Relationships between endpoints

↥

Index endpoint: H7_REFRAACCOMMODIS – Disorders of refraction and accommodation

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Disorders of refraction and accommodation

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints